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Abstract 
The wide scale use of ZnO nanoparticles (NPs) in the world consumer 
market has resulted in likelihood of exposure to human beings. The present 
study was aimed to assess the in vitro and in vivo interactions of ZnO NPs in 
the mammalian system and to elucidate the possible mechanism of their 
toxicity.  
Our in vitro results using human epidermal cells (A431), primary human 
epidermal keratinocytes and human liver cells (HepG2) demonstrated that 
cells exposed to ZnO NPs exhibit a decrease in cell viability which was 
independent of NP dissolution. ZnO NPs also induced oxidative DNA 
damage as evidenced by an increase in the Fpg sensitive sites. The reactive 
oxygen species triggered a decrease in mitochondrial membrane potential 
and an increase in the ratio of Bax/Bcl2 leading to apoptosis through the 
intrinsic pathway. In addition, ZnO NPs induced phosphorylation of JNK, P38 
and P53ser15. The results from our in vivo studies using a mouse model 
showed that ZnO NPs induce lipid peroxidation, oxidative DNA damage and 
apoptosis in liver which further confirmed our in vitro findings. 
The data from the present study provide valuable insights into the cellular 
interactions of ZnO NPs and the underlying molecular mechanism of their 
toxicity. The results also stress the need for a comprehensive environmental 
health and safety assessment of engineered nanomaterials to ensure safer 
nanotechnology based products.  
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1.1. Nanoparticles 
Nanotechnology holds great potential for creating new materials with 
enhanced properties. A number of nanotech based products are finding 
applications in industries, medical devices, imaging, sports, biosensing, 
electronics, drugs, environmental cleanup, cosmetics and sunscreens etc 
(NCPI 2011; USEPA 2007). The global economy will be increasingly 
influenced by nanotechnology as more products containing nanomaterials 
move from research and development into production and commerce 
(Figure 1.1).  
A nanometre (nm) is one billionth of a metre (10-9 m) — about half the size of 
the diameter of DNA. The prefix nano is derived from the Greek word for 
‘dwarf’. The definition for the ‘Nanoparticle’ given in the new PAS71 
document developed by the UK's National Standards Body- British 
Standards Institution (BSI) is: "A particle having one or more dimensions of 
the order of 100nm or less" (PAS71 2005). Nanoparticles are also called as 
ultrafine particles by some toxicologists (USEPA 2007), aitken mode and 
nucleation mode particles by atmospheric scientists (Kulmala 2004; NRC 
1983), and engineered nanoparticles by the materials scientists (NNI 2004). 
1.1.1. Different types of nanoparticles: Nanoparticles can be classified 
into two main categories: natural and anthropogenic nanoparticles. Natural 
nanoparticles existed in the environment long before the nanotechnology era 
started. Examples of natural nanoparticles include soil colloids, airborne 
nano-crystals of sea salts, fullerenes, carbon nanotubes, biogenic magnetite, 
etc. (Buffle 2006; Nowack and Bucheli 2007). Soils contain many kinds of 
inorganic and organic nanoparticles, namely clay minerals, metal oxides and  
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Applications of engineered nanoparticles in the consumer 
products. 
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hydroxides, humic substances, allophane, and imogolite (Theng and Yuan 
2008). Organic nanoparticles can also be found in natural vegetation (Xia et 
al. 2010). Anthropogenic nanoparticles can be further divided into two 
categories: incidental, which are nanoparticles produced unintentionally in 
manmade processes (e.g., carbon black, carbon nanotubes and fullerenes, 
platinum- and rhodium-containing nanoparticles from combustion by-
products (Nowack and Bucheli 2007), and engineered/manufactured, which 
are nanoparticles that are produced intentionally due to their nano-specific 
properties.  
A variety of engineered nanomaterials are already known and more novel 
materials are being engineered. The different ways to produce engineered 
nanoparticles can be categorised in two different classes: “top-down” or 
“bottom-up”. Top down techniques involve etching or milling down a block of 
material to desired shape whereas bottom up involves arranging smaller 
subunits into more complex assemblies (RS/RAE 2004).  
Some of the most widely used nanomaterials are listed below: 
Carbon-based nanomaterials- These nanomaterials are composed mostly 
of carbon, in the shape of a hollow spheres or tubes. Spherical carbon 
nanomaterials are referred to as fullerenes, while cylindrical ones are called 
carbon nanotubes (CNT). There are two types of CNT- single-walled carbon 
nanotube (SWCNT) or multi-walled carbon nanotube (MWCNT). Both of 
these are typically a few nanometres in diameter and several micrometres to 
centimetres long (RS/RAE 2004). 
Metal/ Metal oxide nanoparticles/ nanomaterials- Metal oxide 
nanoparticles have applications in cosmetics, textiles, fuels, drug delivery 
19 
 
and paints. Examples include silver, gold, zinc oxide aluminium oxide, 
cerium oxide and titanium dioxide nanoparticles. 
Quantum dots – Quantum dots (QD) are semiconductor nanocrystals used 
extensively in biomedical imaging. Fluorescent QDs can be conjugated with 
bioactive moieties (e.g., antibodies, receptor, ligands) to target specific 
biologic events and cellular structures (Hardman 2006).  
Dendrimers- Dendrimers are spherical polymeric molecules, formed 
through a nanoscale hierarchical self-assembly process. Dendrimers can act 
as nanoscale carrier molecules and as such could be used in drug delivery 
(RS/RAE 2004). 
1.2. Nanoparticle/ nanomaterials toxicity 
At the nanoscale, the materials have a high surface area to volume ratio 
compared to the same mass of material produced in larger form, as the ratio 
of surface to total atoms or molecules increases exponentially with 
decreasing particle size (Figure 1.2) (Oberdorster et al. 2005). This leads to 
high surface reactivity which affects their strength and physical properties.  
Although the small size and subsequent larger surface area of nanoparticles 
endow them with some highly useful and specific properties, it also renders 
them biologically more active (Figure 1.3) leading to unexpected and 
unanticipated consequences on interaction with biological systems. Smaller 
size also imparts a different biokinetic behaviour and ability to reach more 
distal regions of the body compared to their larger counterparts (Oberdorster 
et al. 2005). The occupational exposure will also increase with the growing 
production and use of nanomaterials in society. Environmental 
contamination is yet another concern. All these apprehensions have  
20 
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Figure 1.2. Surface molecules as a function of particle size (Oberdorster et 
al. 2005) 
 
Figure 1.3. Size- surface area- reactivity paradigm for nanoparticles 
(Downward and upward arrow points to a decrease and increase 
respectively in concerned properties). 
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generated a public debate over understanding and managing the potential 
adverse effects of engineered nanomaterials on human health and the 
environment.  
Government/ regulatory authorities regarding EHS of nanotechnology:   
Governments and scientific authorities all over the world are realizing the 
importance of nanomaterials risk assessment and have undertaken efforts in 
the area. In June 2003, the UK Government commissioned The Royal 
Society and The Royal Academy of Engineering to look into the ethical, 
health and safety issues related to nanotechnology. In their report 
“Nanoscience and Nanotechnologies: Opportunities and Uncertainties” 
published in 2004, The Royal Society recommended that “chemicals in the 
form of nanoparticles or nanotubes should be treated as new substances 
under the existing Notification of New Substances (NONS) regulations and 
in the Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH)” to trigger additional testing for these nanomaterials (RS/RAE 
2004). Committees on the Toxicity, Carcinogenicity and Mutagenicity of 
Chemicals in Food, Consumer Products and the Environment  have also 
identified the risk assessment of nanomaterials as an area of interest in their 
‘Joint Statement on Nanomaterials Toxicology’(COT;COM;COC 2005). 
United States Environmental Protection Agency (USEPA) while recognizing 
the potential benefits of nanotechnology has also stressed on the need for a 
responsible development of nanotechnology and a proactive approach. In its 
document- EPA 100/B-07/001 (Nanotechnology White Paper) published in 
2007, it stated “as the use of nanomaterials in society increases, it is 
reasonable to assume that their presence in environmental media will 
22 
 
increase proportionately, with consequences for human and environmental 
exposure” (USEPA 2007). The European Commission’s Scientific 
Committee on Emerging and Newly Identified Health Risks (SCENIHR) has 
also reviewed the existing literature and issues to be considered in 
conducting risk assessment on nanomaterials (SCENIHR 2009). European 
Commission’s Scientific Committee on Consumer Products (SCCP) issued a 
document titled “Opinion On Safety of Nanomaterials in Cosmetic Products” 
and raised a concern about large data gaps, inappropriateness of existing 
methodologies for nanoparticle risk assessment and inadequate information 
regarding nanoparticles skin absorption in both normal and abnormal 
(diseased) skins (SCCP 2007). Guidance documents on safe handling of 
nanomaterials are also being drafted by researchers (Dhawan et al. 2011). 
The non-governmental organisations like the Friends of the Earth warned 
against nanotechnology in cosmetic and sunscreen products, since they 
may produce a possible uptake of particles by human skin: if nanoparticles 
penetrate the skin, they can join the bloodstream and circulate around the 
body with uptake by cells, tissues and organs (FOE 2006).  
1.3. Biological responses to nanomaterials exposure 
The concerns and awareness related to health and safety aspects of 
nanoparticles have culminated in a number of scientific publications 
concerning toxicological evaluation of nanomaterials. Some of the major 
biological effects exhibited by different categories of nanomaterials have 
been summarized in Table 1.1. 
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Table1.1. Toxicological effects of some widely used nanoparticles (NPs). 
Type of 
NPs 
Toxic effects References 
MWCNT In vitro studies: DNA damage, 
oxidative stress, apoptosis in 
mammalian cells; disrupt actin filament 
integrity and VE-cadherin distribution 
in human aortic endothelial cells. 
 
In vivo studies: Pulmonary toxicity- 
asbestos-like, length-dependent, 
pathogenic behaviour; induce 
inflammation, formation of granuloma, 
cytotoxicity and rapid development of 
fibrosis in lungs; apoptosis of alveolar 
macrophages.  
 
Promote allergic response in mice; 
increased chromosomal aberrations 
and micronuclei frequency; 
suppression of systemic immune 
function through activation of 
cyclooxygenase enzymes in the 
spleen; spotty necrosis, inflammatory 
cell infiltration in portal region, 
hepatocyte mitochondria swelling and 
altered gene expression in liver. 
 
Negative effect on reproduction 
potential, phenotypic defects, 
apoptosis, delayed hatching and 
formation of abnormal spinal cords in 
zebrafish embryo (Danio rerio); toxic 
effects on bacteria. 
 
(Cheng et al. 2009a; Cveticanin 
et al. 2010; Patlolla et al. 
2010a; Ravichandran et al. 
2009; Reddy et al. 2010; 
Walker et al. 2009) 
 
(Crouzier et al. 2010; Elgrabli et 
al. 2008; Han et al. 2010; Ma-
Hock et al. 2009; Poland et al. 
2008; Porter et al. 2010) 
 
 
 
 
(Ji et al. 2009; Mitchell et al. 
2009; Nygaard et al. 2009; Park 
et al. 2009; Patlolla et al. 
2010b) 
 
 
 
 
 
 
 
(Asharani et al. 2008; Cheng et 
al. 2009b; Kang et al. 2008) 
 
Gold NPs Effect on cellular micromotility; 
mitochondrial damage; oxidative 
stress, autophagy in in vitro studies. 
 
In vivo studies: Bioaccumulation in 
important body organs; acute 
inflammation and apoptosis in the 
liver; adverse effect on human sperm 
motility; penetration of gold 
nanoparticles in sperm head and tail. 
 
Adverse effects on rainbow trout 
hepatocytes. 
 
(Li et al. 2010; Pan et al. 2009; 
Tarantola et al. 2009) 
 
 
(Cho et al. 2009b; Lasagna-
Reeves et al. ; Wiwanitkit et al. 
2009) 
 
 
 
 
(Farkas et al. 2010) 
 
Silver NPs In vitro studies: Cytotoxicity and 
chromosome instability, oxidative 
stress, apoptosis, intracellular calcium 
(Asharani et al. 2009a; 
AshaRani et al. 2009b; 
Foldbjerg et al. 2010; Hsin et al. 
24 
 
transients, cell cycle arrest, 
interference with DNA replication 
fidelity, JNK activation in mammalian 
cells. 
 
In vivo studies: Free radical-induced 
oxidative stress and alteration of gene 
expression; blood-brain barrier 
destruction and astrocyte swelling, 
neuronal degeneration; induce brain 
edema formation. 
 
Cytotoxicity and genotoxicity in fish 
cells; NPs accumulation in gill tissue; 
adverse effects on embryonic 
development of oyster, lysosomal 
destabilization of adult oysters; 
oxidative stress, double-strand break 
marker gamma-H2AX and the 
expression of p53 protein, embryonic 
morphological malformations in 
zebrafish. 
 
Induce heat shock stress, oxidative 
stress, DNA damage and apoptosis 
with up-regulation of p53 and p38  
proteins in Drosophila melanogaster. 
 
Decrease in reproduction potential, 
toxicity, oxidative stress in 
Caenorhabditis elegans. 
 
2008; Kawata et al. 2009; Miura 
and Shinohara 2009; Yang et 
al. 2009b) 
 
 
(Rahman et al. 2009; Sharma 
et al. 2010; Tang et al. 2009) 
 
 
 
 
 
(Bar-Ilan et al. 2009; Choi et al. 
2009a; Ringwood et al. 2009b; 
Scown et al. 2010; Wise et al. 
2010) 
 
 
 
 
 
 
 
(Ahamed et al. 2010) 
 
 
 
 
(Roh et al. 2009) 
 
Quantum 
Dots 
In vitro studies: Cytotoxic, induce 
inflammatory response, oxidative 
stress in various types of cell culture 
systems 
 
 
In vivo studies: Transfer of quantum 
dots from pregnant mice to pups 
across the placental barrier; negative 
impact of CdSe-core quantum dots on 
mouse oocyte development; ability to 
penetrate intact and UV radiation 
compromised skin barrier 
 
Phototoxic in Daphnia magna under 
environmentally relevant UV-B light 
 
(Cho et al. 2007; Li et al. 2009; 
Ryman-Rasmussen et al. 2007; 
Su et al. 2009; Tang et al. 
2008; Wang et al. 2008b; 
Zhang et al. 2007) 
 
(Chu et al. 2010; Hsieh et al. 
2009; Mortensen et al. 2008) 
 
 
 
 
 
 
(Kim et al. 2010b) 
 
SWCNT In vitro studies: Impair human 
macrophage engulfment of apoptotic 
cell corpses; fibrogenic effects in lung 
cells; suppress inflammatory mediator 
responses in human lung epithelium; 
disrupt actin filament integrity and VE-
(Cveticanin et al. 2010; Herzog 
et al. 2009; Lindberg et al. 
2009; Migliore et al. 2010; 
Murray et al. 2009; Pacurari et 
al. 2008; Walker et al. 2009; 
Wang et al. 2010b; Witasp et al. 
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cadherin distribution in human aortic 
endothelial cells; activate MAPKs, AP-
1, NF-kappaB, and Akt in normal and 
malignant human mesothelial cells; 
cause cytotoxicity, oxidative stress, 
apoptosis, induction of  micronuclei 
and double strand breaks of the DNA, 
inflammatory response in various 
mammalian cells. 
 
In vivo studies: Lung inflammation and 
genotoxicity; increased levels of 8-
oxodG in liver and lung; activate 
platelets and accelerate thrombus 
formation in the microcirculation; 
promote allergic response in mice. 
 
Microbial inactivation of diverse 
microbial communities of river water 
and wastewater effluent; locomotor 
impairment and mortality in Drosophila 
melanogaster. 
 
2009; Zhang et al.) 
 
 
 
 
 
 
 
 
 
(Bihari et al. 2010; Folkmann et 
al. 2009; Nygaard et al. 2009; 
Yang et al. 2008) 
 
 
 
 
(Kang et al. 2009; Liu et al. 
2009) 
 
Fullerenes In vitro studies: Oxidative stress and 
DNA damaging potential in different 
mammalian cells.  
 
In vivo studies: Increase in pro-
inflammatory cytokines and Th1 
cytokines in BAL fluid, stronger gene 
expression of the MHC class II 
molecule than MHC class I  and an 
increase in T cell distribution in lungs; 
elevated levels of 8-oxodG in the liver 
and lung.  
 
Antibacterial activity through reactive 
oxygen species production. 
 
Adverse effects on embryonic 
development in oysters; oxidative 
stress and growth inhibition in the 
freshwater fish Carassius auratus after 
chronic exposure; long-term exposure 
caused significant cellular damage in 
the alimentary canal of Daphnia 
magna; upon sub-lethal exposure, the 
mortality rates of gestating daphnids 
increased with time and 
developmental stage, maturation of 
daughter daphnids negatively 
impacted; extracellular oxyradical and 
nitric oxide  production, inflammatory 
response in marine bivalve Mytilus 
hemocytes. 
(Dhawan et al. 2006; Jacobsen 
et al. 2008; Zhang et al. 2009) 
 
 
(Folkmann et al. 2009; Park et 
al. 2010) 
 
 
 
 
 
 
 
(Brunet et al. 2009; Cho et al. 
2009a) 
 
(Canesi et al. 2010; Ringwood 
et al. 2009a; Tao et al. 2009; 
Yang et al. 2009c; Zhu et al. 
2008) 
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Metal 
oxide NPs 
Cytotoxicity, membrane damage, 
inflammatory response, oxidative 
stress, apoptosis, lysosomal 
membrane destabilization, DNA 
damage, alteration of calcium 
homeostatis and gene expression in 
diverse mammalian systems as 
reported in a wide array of in vitro and 
in vivo toxicity studies; reports of 
inhibitory effect of superparamagnetic 
iron oxide nanoparticle on osteogenic 
differentiation; disturbance of the ionic 
homeostasis and the physiological 
functions in hippocampal CA3 
pyramidal neurons by ZnO NPs. 
 
Toxic to Saccharomyces cerevisiae, 
bacteria, nematode Caenorhabditis 
elegans and aquatic species like fish, 
phytoplanktons, zebrafish. 
 
 
(Chen et al. 2010; Choi et al. 
2009b; Eom and Choi 2009; 
Fahmy and Cormier 2009; 
Falck et al. 2009; Huang et al. 
2010; Hussain et al. 2010; 
Karlsson et al. 2008; Karlsson 
et al. 2009; Kim et al. 2010a; 
Midander et al. 2009; Ogami et 
al. 2009; Tsaousi et al. 2010; 
Zhao et al. 2009) 
 
 
 
 
 
 
(Gaiser et al. 2009; Jiang et al. 
2009; Kasemets et al. 2009; Ma 
et al. 2009; Miller et al. 2010; 
Zhu et al. 2009) 
 
Some of the studies mentioned in the above table have not done a proper 
characterization of the nanoparticles before assessing their toxicity. 
Correlating the toxicity of nanoparticles to their physicochemical properties 
becomes difficult in the absence of characterization. Therefore, the results 
from such studies should be carefully considered before reaching any firm 
conclusions.   
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1.4. Exposure to nanoparticles 
1.4.1. Exposure sources 
The exposure of general population to the nanoparticles can occur either 
directly or indirectly (Figure 1.4).  
1.4.1.1. Occupational exposure at work place: In the production 
processes there is a likelihood of exposure during synthesis and recovery 
phases. The nature and probability of the exposure would differ according to 
the specific stage of process. Nanoparticle synthesis and manufacturing can 
also contribute to environmental contamination from industrial effluents or 
spillage during shipping and handling. 
1.4.1.2. Exposure through consumer products: Nanoparticles are being 
used in personal care products such as cosmetics and sunscreens. This 
provides a direct source of exposure to humans and can also enter the 
environment from washing off of consumer products. 
1.4.1.3. Exposure through unintentional release: Nanoparticles being 
used in electronics, tyres, fuel additives and many other products may reach 
the environment either through accidental leakage or during their disposal 
(Simonelli et al. 2007). 
1.4.2. Exposure routes 
Depending on the exposure source, nanoparticles can enter the organism 
through different routes and can have varied health effects. If nanoparticles 
contaminate the air, they will mainly enter the organism by inhalation and 
they will interact with the respiratory system. In the case of dermal exposure, 
nanoparticles have to pass through the skin. When soils or waters are  
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Figure 1.4. Possible exposure to nanoparticles. [Source: Nanosciences and 
nanotechnologies: Opportunities and Uncertainties, Royal Society/Royal 
Academy of Engineering, 2004 (RS/RAE 2004)] 
 
contaminated or nanoparticles are deliberately injected or swallowed, their 
absorption is mainly through the circulatory or gastro-intestinal route. 
1.4.2.1. Inhalation exposure: The most common route of exposure is 
through inhalation. This involves intake of airborne nanoparticles through the 
respiratory system. Inhalation exposure may occur while processing and 
packaging the dry powder during nanomaterials synthesis. 
Some previous studies in rats have indicated that for the same material, 
nanometer particles are more potent than the micrometer particles in 
inducing pulmonary toxicity (Oberdorster et al. 2005). The inhaled 
nanoparticles can target all three regions of the human respiratory tract- the 
nasopharyngeal, tracheobronchial, and alveolar regions. Any foreign body in 
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the respiratory tract may face several clearance mechanisms. The 
mucociliary escalator dominates the clearance from upper airways 
(nasopharyngeal and tracheobronchial region); while clearance from the 
deep lung is predominantly by macrophage phagocytosis. The alveolar 
macrophage is the most important defense mechanism in the alveolar region 
for fine and coarse particles, yet inhaled singlet nanoparticles are not 
efficiently phagocytized by alveolar macrophages (Oberdorster et al. 2005).  
A study based on the inhalation exposure of rats to ultrafine (20nm) and fine 
(200nm) titanium dioxide particles, demonstrated that the ultrafine particles 
cleared significantly slower, showing more translocation to interstitial sites 
and to regional lymph nodes when compared to the fine titanium dioxide 
particles (Oberdorster et al. 1994). The nanoparticles can be introduced into 
the blood circulation from the pulmonary interstitial sites. From the blood 
circulation the particles can be distributed to other target organs like liver 
and spleen. 
1.4.2.2. Dermal exposure: Dermal exposure to nanomaterials has received 
much attention, perhaps due to concerns with occupational exposure and 
the introduction of nanomaterials in cosmetics (Wiesenthal et al. 2011). 
Dermal exposure may also occur during the equipment cleaning and 
maintenance. 
Skin is the largest organ of the body and structured in three layers: the 
epidermis, the dermis, and the subcutaneous layer. It functions as a strict 
barrier to exogenous toxicants and micron sized particles. However, the 
efficiency of dermal barrier against nanoparticles is still to be investigated 
completely. The possible routes for nanoparticle entry through the skin are: 
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inter-cellular, trans-cellular and trans-appendageal (Baroli et al. 2007; 
Crosera et al. 2009). In the intercellular route- the lipid-soluble particles may 
move through lipid medium passing between skin cells whereas in the trans-
cellular route the substance enters the skin cells. The trans-appendageal 
route is through the sweat glands and hair follicles which are scattered all 
over the skin in different densities and may become portals for nanoparticles 
to get through deeper parts of the skin (Zhao et al. 2007). 
1.4.2.3. Gastrointestinal exposure: Nanoparticles can be ingested directly 
when used in food, food packaging, drug delivery and cosmetics. Workers 
can be exposed by unintentional hand-to-mouth transfer of materials. 
Moreover, as they are being used in a wide array of consumer products, 
they may enter the environment by a variety of routes such as discharge of 
industrial waste water and disposal of nanoparticles containing products. 
From the environment they can enter the human body through food chain. In 
addition, some of the nanoparticles can be swallowed into the 
gastrointestinal tract when they are expelled from the mucociliary system of 
the lungs after inhalation exposure (Oberdorster et al. 2005). Nanoparticles 
could be translocated from the lumen of the intestinal tract into different 
organs. Jani et al. (1990) found a particle size-dependent uptake (6.6% of 
the administered 50 nm particles, 5.8% of the 100 nm particles, 0.8% of 1 
μm particles, and 0% for 3 μm particles) of polystyrene particles (ranging 
from 50 to 3,000 nm) by the gastrointestinal mucosa. The particles then 
translocated from the Peyer’s patches into the mesenteric lymph and then to 
systemic organs (i.e., liver, spleen, blood, bone marrow, and kidney). 
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Bockmann et al also found the uptake of the TiO2 nanoparticles from the 
gastrointestinal tract into the blood (Bockmann et al. 2000). 
1.5. Characterization of nanoparticles 
An initial characterization of the test substance is imperative before any 
toxicity screening is initiated. However, nanomaterials demand 
comprehensive characterization, unlike chemical toxicants, where the 
characterization is usually confined to chemical composition and purity 
determination. This is to determine the correct correlation between their 
physicochemical properties and the biological effects they elicit. Proper 
characterization prior to the experiments ensures better repeatability and 
hence greater reliability of results (Berhanu et al. 2009; Powers et al. 2007; 
Sayes and Warheit 2009; Warheit 2008). In addition, the characteristics of 
commercially available particles that are specified by the manufacturer 
sometimes differ from those found by the researcher (Sayes et al. 2007). 
However, since the facilities in most toxicology laboratories are not fully 
comprehensive, the complete characterization of nanoparticles is often 
difficult. In the absence of an elaborate laboratory set-up with all of the 
instruments and skilled manpower required, researchers are compelled to 
exploit the techniques available to them. Therefore, sometimes it is the 
availability of facilities that determines the type of characterization performed 
rather than the study design or experimental needs. Among all of the 
parameters that should be considered for characterization, size is the most 
important, and it is critical for determining the interactions of nanoparticles 
with living systems. Although a variety of methods are available for size 
determination of nanoparticles, most commonly employed techniques are 
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Brunauer-Emmett-Teller (BET), dynamic light scattering (DLS) and 
transmission electron microscopy (TEM). However, another challenge that 
arises here is the disagreement between average sizes and size 
distributions given by different methods. This is obviously not surprising in 
view of the different principles behind the techniques involved. In addition, 
variations in sample preparation methods and instrument operating 
procedures also contribute to measurement differences. However, this may 
lead to confusion about the actual nanoparticle size and size distribution if 
one is not well versed with the principles and technical details of the 
measurement methods involved, as is often the case. 
1.5.1. BET Method: The nanoparticle surface area is an important factor in 
nanoparticle toxicity, as the interaction of the nanoparticles with biological 
systems takes place at their surfaces. The BET method is typically used to 
calculate the surface areas of solids by the physical adsorption of gas 
molecules on to the solid surface. It involves adsorbing a liquid nitrogen 
monolayer on to the surfaces of particles and then measuring the amount of 
nitrogen released upon vaporizing that layer. Thus, the BET surface 
represents the surface area that is freely accessible to gases. The primary 
particle diameter (assumed to be the equivalent sphere diameter) is then 
calculated from the specific surface area and the density of the particles -
data that are already available. Though the merit of this method lies in the 
fact that it provides two parameters simultaneously (size as well as surface 
area), it does have a drawback in that it assumes a monodisperse system of 
average-sized spheres, so it does not account for the size distribution of the 
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particles, which is a key parameter in size-dependent toxicity assessment 
(Powers et al. 2007; Weibel et al. 2005). 
1.5.2. Electron Microscopy: Electron microscopy is the simplest and most 
widely used technique that directly measures particle size, size distribution 
and morphology. However, it is time consuming and requires a sufficient 
number of particles containing the fields to be analyzed before a sound 
statistical assessment can be made. Moreover, it measures a sample in dry 
form, not as a suspension, and requires the drying of samples in vacuum, 
which may alter their properties. Another drawback of this technique is that it 
fails to measure the properties of the sample in the form of a dispersion, 
which is used for experimental exposure (Powers et al. 2007). 
1.5.3. Dynamic light scattering: Among the commonly employed 
techniques for particle characterization, DLS is unique in its ability to provide 
the important parameters of size and size distribution in relevant solvents 
used for exposure risk assessment. It measures time-dependent fluctuations 
in scattering intensity produced by particles in Brownian motion and yields 
size of the particle by applying Stokes-Einstein relationship. The size 
obtained by DLS is usually more than the size measured by TEM or BET. 
For size characterization of nanoparticles during toxicity studies, DLS may 
be considered indispensable compared to TEM or BET as it can measure 
size under conditions that mimic more to the exposure conditions. It can 
provide an idea of the particle suspension stability with respect to time and 
medium. Although the choice of a particular characterization technique 
depends on the type of particle being analyzed and the final application of 
the nanoparticles, it is advisable to perform multi-technique analysis in order 
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to get a broader perspective and a more reliable picture of the particle 
characteristics. 
1.6. Nanoparticle internalization in biological systems 
It has been shown that size plays a critical role in cellular uptake of nano-
structures (Chithrani and Chan 2007). A thorough understanding of the 
mechanisms of nanoparticles entering and leaving the cells could lead to a 
better understanding of NP toxicity as well as improvement in their bio-
medical applications.  
Earlier studies have demonstrated that when nanoparticles are exposed to 
cells at 4oC or in ATP-depleted conditions, the nanoparticles entry into the 
cells is inhibited (Chithrani and Chan 2007; Torchilin et al. 2001). Therefore, 
endocytosis has been proposed as the inferred pathway for cellular uptake 
of nanoparticles than the free diffusion. It can be clathrin mediated 
endocytosis (Panyam et al. 2002), caveolae mediated endocytosis or 
clathrin and caveolae independent endocytosis (Rejman et al. 2004) (Figure 
1.5). 
Accumulation of nanoparticles in the perinuclear region or internalization via 
caveolae-mediated endocytosis to reach endoplasmic reticulum may 
facilitate physical contact of nanoparticles with nuclear pore complexes and 
subsequent transport into the nucleus (Chen and Mikecz 2007). The 
phagocytosis is unlikely to contribute to the nanoparticles uptake into the 
cells. This is evident from the fact that even non-phagocytic cells can 
efficiently internalize nanoparticles and the lower size cut-off described for 
phagocytosis is 500nm (Rupper and Cardelli 2001). 
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Figure 1.5. Inferred pathways of nanoparticle uptake. (1) Clathrin mediated 
endocytosis; (2) Caveolae-mediated endocytosis; (3) Clathrin and caveolae-
independent endocytosis. Early-endo- early endosome; endo-lyso- late 
endosome-lysosome; recy-endo- recycling endosome; ER- endoplasmic 
reticulum; NPC- nuclear pore complex (Chen and Mikecz 2007). 
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Tracking nanoparticle internalization in cellular systems is of utmost 
importance for understanding and correlating the biological effects elicited by 
these nanoparticles. However, the challenge lies in detecting the uptake of 
nanoparticles, the mode of uptake, and the fate of nanoparticles inside the 
cells due to their small size and quantity. 
1.6.1. Electron microscopy: Transmission electron microscopy has been 
the preferred method of studying the cellular uptake of nanoparticles. Apart 
from detecting the intracellular localization, it provides a detailed view of the 
interaction of nanoparticles with cell structures. Due to its high resolution, 
transmission electron microscopy enables the imaging of membrane 
invaginations, vesicle formation, and organelles (Motskin et al. 2009). This 
makes it possible to study the mode of nanoparticle uptake, which is of 
primary importance for understanding the influence of size, shape, surface 
chemistries, coatings, and other factors on nanoparticle uptake (Xia et al. 
2008; Zhang et al. 2009). It also aids in understanding the ultrastructural 
changes that occur in cells subsequent to nanoparticle uptake (Song et al. 
2010; Xie et al. 2009). However, transmission electron microscopy is only a 
qualitative tool for assessing nanoparticle uptake, and is usually confined to 
imaging a few cells due to the complicated sample preparation and image 
analysis involved.  
A scanning electron microscope (SEM) can also be used to observe 
nanoparticles inside cells. For this, backscattered electron detection is used 
instead of the normal secondary electron mode of detection. Backscattered 
electrons (BSE) are high-energy electrons that are reflected or 
backscattered out of the specimen following elastic scattering interactions 
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with specimen atoms (Baroli et al. 2007; Pelka et al. 2009). This enables 
bright nanoparticles to be seen against the cellular dark background, since 
high atomic number elements backscatter electrons more strongly than low 
atomic number elements. In addition to visualizing the specimen, elemental 
analysis of the sample can be achieved by energy-dispersive X-ray 
spectroscopy (EDS) (Bastian et al. 2009; Kuhnel et al. 2009). The staining 
procedures generally used for electron microscopic preparations can 
introduce electron-dense artefacts that may be mistaken for nanoparticles.  
1.6.2. Inductively coupled plasma mass spectroscopy (ICPMS): 
Sometimes very small amounts of nanoparticles in the environment or in 
living systems make it difficult to perform a qualitative assessment by 
microscopic tools. Moreover, electron microscopic techniques become 
ineffective when it comes to the analytical quantification of nanoparticles. In 
this case, ICPMS can be used as a sensitive and quantitative tool for the 
determination of even trace amounts of nanoparticles. ICPMS becomes 
especially important in the context of an in vivo scenario, where it identifies 
the target organs for nanoparticles (Tang et al. 2009). Using this technique, 
even trace amounts of nanoparticles that enter through a different route can 
be detected in various body organs. However, the digestion step involved in 
the sample preparation method for ICPMS may lead to contamination and 
dilution, and it makes it difficult to differentiate between ions formed as a 
result of nanoparticle dissolution and nanoparticles per se (Allabashi et al. 
2009; Marquis et al. 2009). 
1.6.3. Flow cytometry:  Flow cytometry is yet another technique that can be 
used to study nanoparticle uptake in mammalian cells (Missirlis and Hubbell 
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2009; Suzuki et al. 2007; Wang and Wu 2006; Xu et al. 2009). It is not only 
simple, easy and sensitive, but it is also a cost-effective and non-invasive 
approach. In this method, a laser beam is made to strike a hydrodynamically 
focused stream of fluid containing a single cell suspension, and a number of 
detectors then collect information on how the light interacts with the cells. 
Some of the photons that hit the edge of the cell are deflected slightly, and 
this forward scattered light corresponds to the size of the cells. Photons 
scattered at right angle to the laser beam (side scatter) indicate the inner 
complexity or granularity of the cells. Fluorescence emitted by the structures 
present inside the cells or attached to the cells is also picked up by the 
detector, providing an array of useful information (Figure. 1.6). Thus, flow 
cytometry can be used for the detection of fluorescent as well as non-
fluorescent nanoparticles inside the cells. In fluorescent nanoparticles, the 
forward-scattered light remains constant in exposed and unexposed cells, 
while the intensity of side-scattered light increases in proportion to the 
concentration of nanoparticles inside the cells. The sensitivity of side 
scattering should be kept low in order to detect a broad range of changes in 
uptake (Suzuki et al. 2007). Sample preparation for flow cytometry analysis 
is much simpler than for other analytical techniques. Cells exposed to 
nanoparticles are washed, trypsinized and then re-suspended in buffer for 
flow cytometry acquisition. Suzuki et al. (2007) used flow cytometry to show 
that the TiO2 nanoparticles were taken up by the cultured mammalian cells 
in a dose-, time- and size dependent manner (Suzuki et al. 2007). In 
addition, they also revealed a change in the uptake potential on a surface 
coating, which was shown by the intensity of the side-scattered light  
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Figure 1.6. Analysing nanoparticle (NP) uptake in cells by flow cytometry- 
(A) Light scattering by a cell having no association with any nanoparticle; (B) 
Nanoparticles adhered to cell surface leading to increase in forward scatter 
(FSC) and side scatter (SSC); (C) Nanoparticle internalization by cell leading 
to increase in SSC alone; (D) Fluorescent nanoparticle internalization by cell 
leading to increase in SSC and fluorescent intensity (FL). 
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(Suzuki et al. 2007). The uptake of fluorescent amphiphilic hydrogel 
nanoparticles by a murine macrophage cell line (J774A.1) was demonstrated 
by determining the fluorescent intensities of exposed cells (Missirlis and 
Hubbell 2009). The uptake mechanism was also elucidated by selectively 
inhibiting cellular internalization processes with a variety of inhibitors and 
then analyzing the cells by flow cytometry (Missirlis and Hubbell 2009). The 
applicability of flow cytometry for studying the cellular internalization of 
nanoparticles was also utilized in an in vivo study investigating the 
phagocytic uptake of nanoparticles by mouse peritoneal macrophages 
(Wang and Wu 2006). Flow cytometric analysis of nanoparticle uptake in 
cells can be further supported by fluorescent spectroscopy or microscopy 
data in the case of fluorescent nanoparticles. Despite its many advantages, 
the main drawback of flow cytometry in nanoparticle uptake studies is that it 
can only show the association of nanoparticles with cells but does not 
indicate their localization and fate inside the cells. 
1.7. Agglomeration and dispersion 
The tendency of nanoparticles to agglomerate both in dry as well as in wet 
state is another significant technical challenge encountered while dealing 
with nanomaterials. The phenomenon of agglomeration involves adhesion of 
particles to each other mainly due to Van der Waal’s forces which become 
quite prominent at nanoscale due to increased surface area to volume ratio 
(Powers et al. 2007) (Figure 1.7). The challenge for synthetic chemists is to 
prevent surface particle interactions to ensure that the nanoparticles do not 
agglomerate, especially in biologically relevant fluids. Brownian motion, in 
combination with Van der Waal’s forces, also contributes significantly to the  
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Figure 1.7. Schematic showing the phenomenon of agglomeration of 
nanoparticles. 
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agglomeration of nanoparticles, which ultimately settle down due to 
gravitational forces. Due to agglomeration, the physicochemical properties 
and the number concentration of the nanoparticles get altered. The major 
properties affected are their size, size distribution, surface-to-volume ratio, 
and hence their surface reactivity. Since these parameters play a major role 
in the toxicity of nanoparticles, and are altered due to agglomeration, it is 
prudent to account for these changes in the study design (Borm et al. 2006; 
Teeguarden et al. 2007). 
It is well known that nanoparticles can traverse through biological barriers 
due to their size. Hence, agglomeration could alter biological responses due 
to a decrease in the total available surface area, leading to an 
underestimation of toxic potential (Sager et al. 2008). The rate and extent of 
agglomeration of nanoparticles could vary after they enter cells, due to their 
interaction with macromolecules (Balbus et al. 2007). Though different 
methods are available to deagglomerate nanoparticles (sonication, 
detergents, lung surfactants, polyethylene glycol, serum, etc.), sonication is 
the most preferable and widely used method. It disperses nanoparticles in a 
liquid by cavitation and does not have much effect on the properties of the 
particles. 
Agglomeration is a challenge to the accurate interpretation of the biological 
response to any given nanomaterial. This is evidenced by an increase in the 
cytotoxicity when mesothelioma cells (MSTO-211H) are exposed to micron-
sized agglomerates of carbon nanotubes rather than well-dispersed carbon 
nanotubes (dispersed with a non-ionic biocompatible surfactant, PS80). This 
is because the structural characteristics of the material change after 
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agglomeration; it becomes stiffer and behaves like asbestos particles (Wick 
et al. 2007).  
Another important method of preventing the agglomeration of nanoparticles 
and homogeneously dispersing them in liquids is surface modification 
(Figure 1.7). This can be achieved in various ways, depending on the 
application. The particles can be coated with polymers or dispersed in ionic 
or nonionic surfactants or alveolar surfactants (Farah et al. 2008; Sager et 
al. 2008; Skebo et al. 2007; Wick et al. 2007). While surface modifications 
allow the particles to be stabilized and avoids agglomeration, it also raises 
concern that they may shield or influence the effects of nanomaterials on 
biological systems (Derfus et al. 2004; Warheit 2008; Warheit et al. 2005). 
The durability or stability of such surface coatings inside a biological 
environment is another critical issue that needs to be understood in order to 
unravel the toxicological consequences of nanoparticles. Quantum dot (QD) 
cores possess unique optical and electrical properties, but these cores are 
coated with different materials to make them biologically compatible/active 
(Hardman 2006). However, Hoshino et al. (2004) reported that the exposure 
of QD surface coatings to the acidic and oxidative environments of 
endosomes may cause their decomposition and subsequent release into 
cytoplasm. This can in turn expose the metalloid core, which may be toxic or 
pave the way for unforeseen reactions of the QD inside the cellular 
environment. 
1.8. Oxidative stress 
Oxidative stress has been proposed as a possible mechanism involved in 
the toxicity of nanoparticles (Nel et al. 2006). Oxidative stress can be defined 
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as a disturbance in the pro-oxidant–antioxidant balance in favour of the 
former, leading to cellular damage (Halliwell and Whiteman 2004). Oxidative 
stress is induced in cells as a result of one of two factors: 1) an increase in 
reactive oxygen species (ROS) generation, or 2) a decrease in antioxidant 
protection. ROS are either free radicals, reactive anions containing oxygen 
atoms, or molecules containing oxygen atoms that can either produce free 
radicals or are chemically activated by them. Examples are hydroxyl radical 
(•OH), superoxide, hydrogen peroxide etc (Vigneron and Vousden 2010). 
Some of those molecules are extremely reactive, such as the hydroxyl 
radical, while some are less reactive (superoxide and hydrogen peroxide).  
A beneficial physiological use of ROS in cells is in intracellular signalling 
(Forman 2010; Thannickal and Fanburg 2000). However, at high levels 
cellular damage occurs which results from the ROS-induced alteration of 
macromolecules such as polyunsaturated fatty acids in membrane lipids, 
essential proteins, and DNA (Roberts et al. 2010). 
1.8.1. Effect on DNA: ROS attack on DNA generates a huge range of base 
and sugar modification products. A number of alterations in DNA (e.g., 
cleavage of DNA, DNA-protein cross links, oxidation of purines, etc.) are due 
to reactions with ROS, especially hydroxyl radical (Marnett 2000). It is known 
that oxidised bases such as 8-oxoguanine (8-oxoGua) are potentially 
mutagenic, because of alteration in the base pairing properties (8-oxoGua 
pairs with adenine instead of cytosine) (Collins 2009). If the DNA repair 
systems are not able to immediately regenerate intact DNA, a mutation will 
result from erroneous base pairing during replication. This is the reason for 
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high prevalence of cancer in individuals exposed to oxidative stress (Mates 
et al. 1999). 
1.8.2. Effect on apoptosis: Moderate oxidative stress induces apoptosis, 
whereas necrosis occurs at higher levels of oxidative stress. Signalling 
pathways that are activated by ROS and leads to apoptosis are the 
activation of JNK and p53 (Circu and Aw 2010) (Figure 1.8). ROS production 
causes dimerisation of Bax in the cytosol by generating disulfide bridges 
between critical cysteine residues (Neuzil et al. 2006). This changes the 
conformation of Bax, exposing the docking motif which then moves to the 
mitochondrial outer membrane where Bax dimers aggregate to form pores 
(D'Alessio et al. 2005).  This results in release of pro-apoptotic factors and 
subsequently apoptotic cell death. 
1.8.3. Effect on cell membrane: The lipids present in the cell membrane 
can be oxidized by ROS. Polyunsaturated fatty acids because of their 
multiple double bonds are excellent targets for free radical attacks. This 
leads to membrane damage and further production of free radicals as well 
as mutagenic compounds (Negre-Salvayre et al. 2010). 
1.8.4. Measurement of oxidative stress in cells 
Apart from measurement of ROS directly and oxidatively damaged DNA, 
measurement of some other biomarkers can also predict the state of 
oxidative stress in cells.  
1.8.4.1. ROS generation: The intracellular generation of ROS can be 
measured by dichlorofluorescin diacetate (DCFDA). DCFDA is deacetylated 
by esterases to dichlorofluorescin (DCFH). This non-fluorescent product is 
converted by ROS into DCF, which can easily be visualized by strong 
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fluorescence at around 525nm when excited at around 488 nm (Halliwell and 
Whiteman 2004). 
1.8.4.2. Lipid peroxidation: Lipid peroxidation refers to the oxidative 
degradation of lipids. Lipid peroxidation generates a complex variety of 
products, many of which are reactive electrophiles. Some of these are toxic 
and mutagenic and react with protein and DNA. ROS such as hydroxyl 
radical acts as initiator of lipid peroxidation by combining with a hydrogen 
atom (in methylene group of polyunsaturated fatty acids) to make water and 
a fatty acid radical. The later being an unstable species reacts with another 
free fatty acid producing a different fatty acid radical and a lipid peroxide 
(Catala 2010). These fatty acid radicals are neutralized in the cell membrane 
by either another molecule of fatty acid or vitamin E. 
1.8.4.3. Glutathione: Glutathione (GSH) is the most abundant intracellular 
thiol-based antioxidant, synthesized in the body from the amino acids L-
cysteine, L-glutamic acid and glycine (Lu 2009). Glutathione exists in 
reduced (GSH) and oxidized (GSSG) states. In the reduced state, the thiol 
group of cysteine is able to donate a proton to other unstable molecules, 
such as ROS. In donating a proton, glutathione itself becomes reactive, but 
reacts with another reactive glutathione to form glutathione disulphide 
(GSSG). GSH can be regenerated from GSSG by the enzyme glutathione 
reductase (Biswas and Rahman 2009; Franco and Cidlowski 2009). 
Oxidized glutathione (GSSG) is reduced by the NADPH-dependent 
flavoenzyme glutathione reductase (GR). Glutathione S-transferases (GST) 
catalyze the conjugation of glutathione with other molecules, thereby 
47 
 
functioning as an intermediate step in the detoxification of miscellaneous 
toxic substances (Van Bladeren 2000). 
1.8.4.4. Superoxide dismutase: Superoxide dismutases (SOD) are the 
superoxide metabolizing enzyme. In eukaryotes, there are two SOD 
isoenzymes Mn-SOD present in mitochondria, and the Cu/Zn-SOD present 
in the cytosol (McCord and Fridovich 1969) The formation of superoxide 
takes place as a result of leakage of electrons from electron transport chain 
present in the mitochondrial inner membrane. They are also produced 
endogenously by flavoenzymes and by activated phagocytes. The 
superoxide dismutases (SOD) catalyze the conversion of superoxide anion 
into hydrogen and oxygen. The superoxide anion is created from molecular 
oxygen by the addition of an electron. In spite of being a free radical, it is not 
highly reactive. It lacks the ability to penetrate lipid membranes and is 
therefore enclosed in the compartment where it was produced. However, the 
Fenton reaction can facilitate the conversion of superoxide anion and 
hydrogen peroxide to hydroxyl radical.  
1.8.4.5. Catalase: Catalases of many organisms are mainly heme-
containing enzymes (Vlasits et al. 2010). Their predominant subcellular 
localization in mammalian cells is in peroxisomes. The catalases carry out a 
dismutation reaction in which one molecule of H2O2 oxidizes another such 
that the one is converted to O2 and the other to two molecules of water 
(Zamocky et al. 2008). Hydrogen peroxide is not a free radical itself but can 
give rise to highly reactive hydroxyl radical via oxidation of transition metals 
often bound in complex with different proteins or other molecules. Thus 
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catalase lowers the risk of hydroxyl radical formation (Nordberg and Arner 
2001). 
1.9. Genotoxicity 
Genotoxicity refers to the ability of a test substance to induce DNA damage. 
The incidence of DNA damage is likely to be more in cells subjected to 
unfavourable conditions such as inflammation or tobacco smoke exposure.  
1.9.1. Types of DNA damages 
Alteration of bases: Alkylating agents include nitrogen and sulfur mustards, 
methyl and ethyl methane sulfonate (MMS and EMS) and nitrosoguanodine. 
These chemicals donate alkyl groups to other molecules and induce 
mutations (Figure 1.8) (Gocke et al. 2009).  For example, EMS causes 
ethylation of the bases in DNA at the 7-N and the 6-O positions.  When 7-
ethylguanine is produced, it base pairs with thymine to cause G: C to A: T 
transition mutation.   
Absorption of the ultraviolet radiation causes the adjacent thymine residues 
in a DNA strand to be joined by formation of the bond resulting in thymine 
dimer formation (Narayanan et al. 2010). 
Single strand breaks: A variety of agents can break phosphodiester bonds.  
Among the more common chemicals are peroxides, sulfhydryl containing 
compounds (Driessens et al. 2009). Ionizing radiation can produce strand 
breaks by action of secondary electrons produced by β- particle or an X- ray 
photon (Ayene et al. 2007; Rakhorst et al. 2006; Stap et al. 2008).  
Double strand breaks: If a DNA molecule receives a sufficiently large 
number of randomly located single strand breaks, two situated opposite to 
one another results in breakage of double helix. Double strand breaks result 
49 
 
from exposure to highly ionizing radiation (e.g. χ- rays and γ -rays, electron 
beams etc.) (Bassing et al. 2002). 
DNA crosslinks: Some antibiotics i.e. mitomycin C and reagents (nitrite ion) 
can form covalent linkages between a base in one strand and an opposite 
base in the complementary DNA strand (Hlavin et al. 2010). This prevents 
strand separation during DNA replication and also causes local distortion of 
the helix. 
In general, some main sources of DNA damage are DNA- adducts forming 
molecules, intercalating agents and reactive oxygen species (ROS). In 
addition to these two major sources of DNA damage, another well 
recognized source is the ultraviolet (UV) component of sunlight, which is the 
key risk factor for malignant melanoma. The DNA damage induced by UV is 
primarily in the form of pyrimidine dimers. An example of DNA-adduct 
forming molecule is benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE).  
1.9.2. Nanoparticle induced DNA damage 
Genotoxicity is a central element of risk assessment for any chemical 
compound that humans may be routinely exposed to (e.g. in foods or 
personal care products). Information about genotoxicity is vital as DNA 
damage can not only initiate cancer development, but can also have an 
impact upon fertility and the health of subsequent generations if 
disturbances arise in reproductive cells (Singh et al. 2009). Nanoparticles 
have been demonstrated to possess genotoxic potential (Karlsson 2010) 
which may be attributed to following main reasons: 
1.9.2.1. Direct interactions with the DNA: Nanoparticles may gain direct 
access to DNA after transport into the nucleus  
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Figure 1.8. Spectrum of DNA damage induced by physical and chemical 
agents (adapted from Casserette and Doull;s “Toxicology: the basic science 
of poison” Genetic Toxicology, pp 326).  
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(Chen and Mikecz 2005). The entry of nanoparticles into the nucleus has 
been demonstrated by earlier studies (Alkilany and Murphy 2010; Shukla et 
al. 2011). Moreover, even if the nanoparticles are unable to cross the 
nuclear membrane but are able to accumulate in the cytoplasm, they can still 
gain access to the nucleus during mitosis when the nuclear membrane 
breaks down (Singh et al. 2009). The direct interaction of nanoparticles with 
the DNA and DNA-related protein may lead to physical damage to the 
genetic material.  
Interference with the structure or function of DNA repair enzymes in the 
nucleus might be another reason for DNA damage. The transport of 
quantum dots in the cell nucleus via nuclear pore complex with subsequent 
targeting of histones has been reported earlier. 
1.9.2.2. Oxidative DNA damage: The nanomaterials due to their high 
surface area to volume ratio are known to produce reactive oxidative species 
(ROS). A previous study showed that the perinuclear distribution of TiO2 
nanoparticles in BEAS-2B cells correlated with the induction of ROS in the 
same region as visualized by a fluorescence dye. ROS can induce DNA 
damage in the form of single and double stranded DNA breaks, base 
modifications and DNA cross-links (Toyokuni 1998). The other way to 
produce ROS is by interacting with the cellular organelles. It can be by 
particle-induced disturbance of the mitochondrial electron transport chain 
function (Li et al. 2003). The ROS can also be generated during particle 
elicited inflammation. Inflammation from activated phagocytes 
(macrophages, neutrophils) produces bursts of ROS in order to destroy 
invading pathogens (Hussain et al. 2007). These ROS can damage the DNA 
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of the infecting pathogen, the DNA of invaded cells, and also nearby host 
cells that were not invaded. 
1.9.3. Comet assay/ Single cell gel electrophoresis 
The Single Cell Gel Electrophoresis, also known as Comet assay is a well 
established, simple, rapid, visual and a sensitive, extensively used 
biomarker to assess DNA damage quantitatively as well as qualitatively in 
individual cell population (Collins 2004). It has gained wide acceptance as a 
valuable tool in fundamental DNA damage and repair studies (Speit and 
Hartmann 2006), genotoxicity testing (Moller 2005) and population 
biomonitoring (Garcia-Leston et al. 2011).  
1.9.3.1. Principle 
The methods of detection of DNA strand breaks are based on the principle 
that strand breaking or DNA damaging agents reduce the size of the large 
duplex DNA molecule. Single and double strand breaks adversely affect the 
super-coiling and packaging in the nucleus. The lysis step removes cell 
membranes, bulk of proteins, cytoplasm and nucleoplasm, and disrupts 
nucleosomes and histones. The nucleoid which is left behind, consist of a 
nuclear matrix composed of ribonucleic acid (RNA), proteins and negatively 
supercoiled DNA (Collins 2004). Any breaks present in the DNA cause the 
super coiling to relax locally and loops of DNA are then free. A high pH 
facilitates denaturation of DNA (because of the disruption of hydrogen bonds 
between double-stranded DNA) and expression of alkali labile sites as 
breaks. The electrophoresis would pull the damaged DNA towards the 
anode thus making the distinct ‘tail’ of the comet visible after fluorescent 
staining. Various modifications of the Comet assay protocol to suit the cell 
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type or experiment have been made during the years (Fairbairn et al. 1995; 
Speit and Hartmann 2006). 
1.9.3.2. Advantages  
The Comet assay has various advantages over other DNA damage 
detecting tests. These include its application in detecting DNA damage at 
single cell level in proliferating and non-proliferating cell population, and in 
cells of tissues, which are the first site of contact with mutagenic/ 
carcinogenic substances (e.g. oral and nasal mucosal cells). The assay 
requires small number of cells per sample (~ 10,000) and has a higher 
sensitivity for detecting DNA damage (detects as few as one DNA break per 
1010 Dalton) as compared with other techniques. It can also be used to 
detect specific classes of DNA adducts (e.g. thymidine dimers, oxidative 
damage) by using lesion specific antibodies or specific DNA repair enzymes. 
The collection of the data at the level of the individual cells allows robust 
types of statistical analysis. Therefore, it has wide acceptance in fields 
ranging from molecular epidemiology to genetic toxicology. 
The Comet assay has proved to be a versatile, simple and the most useful 
technique for the detection of a wide range of DNA damage and repair 
processes in single cells and is the test of choice in preliminary screening of 
chemical entities for their genotoxic potential.  
1.10. Apoptosis 
The apoptotsis (programmed cell death) is an active and defined process 
which plays an important role in the development of multicellular organisms 
and in the regulation and maintenance of the cell populations in tissues upon 
pathological conditions. Cells undergoing apoptosis show characteristic 
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morphological features: the cell shrinks, loses contact with its neighbouring 
cells, chromatin condenses, the plasma membrane is blebbing or budding, 
and finally the cell is fragmented into compact membrane-enclosed 
structures, called 'apoptotic bodies'. The apoptotic bodies are engulfed by 
macrophages and removed without causing an inflammatory response.  
Apoptosis can be triggered by various stimuli from outside or inside the cell, 
e.g. by ligation of cell surface receptors, by DNA damage, treatment with 
cytotoxic drugs or irradiation, by a lack of survival signals or oxidative stress. 
Molecular mechanism of apoptosis signalling pathways 
1.10.1. Intrinsic (mitochondrial) apoptotic pathway: The pro-apoptotic 
proteins Bax, Bad, Bid, Bik, and Bim contain an alpha-helical BH3 death 
domain that fits the hydrophobic BH3 binding pocket on the anti-apoptotic 
proteins Bcl-2 and Bcl-XL, forming heterodimers that block the survival-
promoting activity of Bcl-2 and Bcl-XL. Thus, the relative abundance of pro-
apoptotic and anti-apoptotic proteins determines the susceptibility of the cell 
to programmed death (Lee and Wei 2000). The pro-apoptotic proteins act on 
the surface of the mitochondrial membrane to decrease the mitochondrial 
trans-membrane potential and promote leakage of cytochrome C. 
Cytochrome C, a key protein in electron transport, appears to act by forming 
a multimeric complex with Apaf-1, which in turn activates procaspase 9, and 
begins a Caspase cascade resulting in apoptosis (Budihardjo et al. 1999) 
(Figure 1.9). 
1.10.2. Extrinsic (death receptor) apoptotic pathway: The extrinsic 
signaling pathways that initiate apoptosis involve trans-membrane receptor-
mediated interactions (Elmore 2007). These involve death receptors that are  
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Figure 1.9. The intrinsic and extrinsic apoptotic pathway (Vucic and 
Fairbrother 2007). 
 
 
 
 
 
 
 
56 
 
members of the tumour necrosis factor (TNF) receptor gene superfamily. 
Upon ligation by its cognate ligand, the death receptor recruits adaptor 
molecules via its cytoplasmic death domains. The binding of Fas ligand to 
Fas receptor results in the binding of the adapter protein FADD and the 
binding of TNF ligand to TNF receptor results in the binding of the adapter 
protein TRADD. FADD then associates with procaspase-8 via dimerization 
of the death effector domain. At this point, a death-inducing signaling 
complex (DISC) is formed. When bound to the DISC, several procaspase-8 
molecules are in close proximity to each other and therefore are assumed to 
activate each other by auto-proteolysis (Denault and Salvesen 2002). The 
initiatior caspase-8 activates effector caspases for the execution of 
apoptosis (Figure 1.9). 
1.11. Mitogen activated protein kinase (MAPK) signalling pathways 
Mitogen-activated protein (MAP) kinases are serine/threonine-specific 
protein kinases that respond to extracellular stimuli and regulate various 
cellular activities, such as gene expression, mitosis, differentiation, 
proliferation, and cell survival/apoptosis. MAPK signaling cascades are 
organized hierarchically into three-tiered modules. MAPKs are 
phosphorylated and activated by MAPK-kinases (MAPKKs), which in turn 
are phosphorylated and activated by MAPKK-kinases (MAPKKKs). The 
MAPKKKs are in turn activated by interaction with the family of small 
GTPases and/or other protein kinases, connecting the MAPK module to cell 
surface receptors or external stimuli (Zhang and Dong 2007). In mammals, 
three major MAPK pathways have been identified (Figure 1.10) which are 
mentioned below: 
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Figure 1.10. Mammalian MAPK cacades. There are four major mammalian 
MAPKKK–MAPKK–MAPK protein kinase cascades. The ERK pathway is 
commonly activated by growth factors, the JNK, p38 and ERK5 pathways 
are activated by environmental stress (Roberts and Der 2007).  
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1.11.1. Extracellular-signal-regulated kinase (ERK) pathway: These are 
widely expressed molecules that are involved in functions including the 
regulation of meiosis and mitosis in differentiated cells. Many different 
stimuli, including growth factors, cytokines, virus infection and carcinogens 
activate the ERK pathway (Boulton and Cobb 1991). Phosphorylation of 
ERKs leads to the activation of their kinase activity. 
1.11.2. JNK pathway: c-Jun N-terminal kinase (JNK, also known as stress-
activated protein kinase (SAPK)) is one of the leading candidate signal 
transduction mechanisms that transmits and converts stress signaling into 
apoptosis signaling in various cell types (Davis et al. 2007). The JNK 
pathway has been identified as a direct activator of the mitochondrial death 
machinery providing a molecular linkage from oxidative stress to the 
mitochondrial apoptosis machinery. It is known to cause the release of 
cytochrome c and AIF by selective permeabilization of the outer 
mitochondrial membrane (Aoki et al. 2002). Anti-apoptotic Bcl2 family 
proteins, namely Bcl2 and BclxL were found to be phosphorylated by JNK 
suppressing their anti-apoptotic function (Maundrell et al. 1997). 
1.11.3. p38 pathway: p38 MAPKs (α, β, γ, and δ) are members of the 
MAPK family that are activated by a variety of environmental stresses and 
inflammatory cytokines. p38 MAPK is involved in regulation of HSP27 and 
several transcription factors including ATF-2, Stat1, the Max/Myc complex, 
MEF-2, Elk-1 and indirectly CREB via activation of MSK1 (Coulthard et al. 
2009) Most stimuli that activate p38 also activate JNK.  
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1.12. Zinc oxide nanoparticles 
Zinc oxide is one of the most commonly used nanoparticles with wide 
ranging applications in various industrial and consumer products. The global 
production of the nanoparticle for sunscreen products was estimated to be 
approximately 1000 tons during 2003/2004 (Borm et al. 2006), and 
principally consisted of TiO2 and ZnO particles. 
It forms an essential constituent of sunscreens and other dermatological 
preparations owing to its transparent appearance in nano form (Schilling et 
al. 2010). The sunscreens with traditional large sized ZnO particles appear 
white on skin. This is due to the reason that when light encounters a cluster 
of atoms or ions suspended in another medium, it gets scattered in multiple 
directions. The wavelength of light that is reflected/scattered from an object 
and reaches our eyes gives the object its colour. Scattering depends on 
cluster size and maximum scattering occurs when the wavelength is twice as 
large as the cluster size (Figure 1.11). Since traditional inorganic sunscreen 
ingredients have a diameter > 200nm, they scatter light which is near 400nm 
which includes light in the visible spectrum. The combination of different 
colours of visible light is white so the sunscreen appears white. However, the 
ZnO nanoparticles (<100nm) are too small to scatter visible light. The visible 
light passes through the sunscreen to the skin, interacts with the pigment 
melanin and the skin appears ‘skin coloured’ (Figure 1.12). 
ZnO nanoparticles are also finding their way into the food industry in the 
form of additives and in packaging in view of their antimicrobial properties 
(Gerloff et al. 2009; Jin et al. 2009). They are being used in solar driven self 
coatings (Cai et al. 2006). They are being explored further by the  
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Figure 1.11. Scattering of light for 100nm and 200nm ZnO particles. 
(Source: www.nanosense.org). 
 
 
 
 
Figure 1.12. Interaction of visible light with different sized particles of ZnO 
(A) Large particles (>200nm) scatter visible light (B) Nanoparticles (<100nm) 
do not scatter visible light and let it interact with melanin (Source: 
www.nanosense.org). 
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nanotechnology researchers for developing diverse applications such as 
fungicides in agriculture (He et al. 2010), catalyst (Jung and Choi 2006) for 
use in fabrics (Yadav et al. 2006; Yuranova et al. 2007) and also in 
biomedical applications (John et al., 2010; Rasmussen et al. 2010). 
ZnO is considered to be a ‘GRAS’ (generally recognized as safe) substance 
by the Food and drug administration (FDA), USA. However, the GRAS 
category refers to materials in the larger size range and even these 
substances when reduced to the nanoscale can develop new properties and 
thus may produce toxic effects. Some studies have demonstrated that ZnO 
nanoparticles were toxic to varying degrees to the bacteria (Reddy et al. 
2010; Sinha et al. 2010), the eco-relevant species  (Franklin et al. 2007; Zhu 
et al. 2009) and the mammalian cells (Gojova et al. 2007; Jeng and 
Swanson 2006; Osman et al. 2010; Yang et al. 2009b). However, the 
mechanisms of its toxicity are not well understood. 
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1.13. Aims and objectives of the study 
The increased use of ZnO nanoparticles has aroused concerns regarding its 
unintentional health and environmental impacts. It is therefore prudent to 
study its toxicological effects on human health. The overall aim of the 
present study was to assess the in vitro and in vivo toxicity of ZnO 
nanoparticles in the mammalian system and to elucidate the possible 
mechanism of its toxicity. This was achieved by the following objectives: 
1. To assess the uptake, cytotoxicity and genotoxicity of ZnO 
nanoparticles in human epidermal cells (human epidermal cell line 
and primary human epidermal keratinocytes). 
2. To evaluate the cytotoxic and genotoxic potential of ZnO 
nanoparticles in human liver cells (HepG2) and elucidating the 
mechanism of its toxicity 
3. To investigate the in vivo toxicity of ZnO nanoparticles in mice after 
acute exposure via oral administration. 
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This chapter is a description of the chemicals, methods and instruments 
used in the present study. A visual display of various techniques used is 
given in Table 2.1. 
Table 2.1. The techniques used in the present study. 
Dynamic light 
scattering 
 
Transmission 
electron microscopy 
 
Scanning electron 
microscopy 
 
Flow cytometry 
 
MTT assay 
 
Neutral red uptake 
assay 
 
Lactate 
dehydrogenase 
release assay 
 
Measurement of 
reactive oxygen 
species 
 
Lipid peroxidation 
assay 
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GSH
CatalaseOxidative stress 
enzyme assays 
  
Comet assay 
 
AnnexinV/PI double 
staining 
 
Hoechst staining 
 
Mitochondrial 
membrane potential 
 
Histopathology 
 
TUNEL assay 
 
Western blot analysis  
 
 
 
 
 
 
SOD
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2.1. Chemicals 
Zinc oxide nanopowder (CAS No. 1314-13-2; purity >99%), neutral red dye, 
low melting point agarose (LMA), ethidium bromide (EtBr), Triton X-100, N-
acetyl cysteine (NAC), Zinc chloride (ZnCl2), SP600125, SB203580, Na-
orthovanadate, Na-fluoride, Ponceau S stain, protease inhibitor cocktail were 
purchased from Sigma Chemical Co. Ltd. (St. Louis, MO, USA). Normal 
melting agarose (NMA), ethylenediaminetetraacetic acid (EDTA) disodium 
salt, and (3-(4, 5-dimethyl- thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide 
(MTT) dye were purchased from Hi-media Pvt. Ltd. (Mumbai, India). 
Phosphate buffered saline (Ca2+, Mg2+ free; PBS), minimal essential 
medium (MEM), Dulbecco’s minimal essential medium (DMEM), trypsin–
EDTA, fetal bovine serum (FBS), trypan blue, antibiotic and antimycotic 
solution (10,000 U/ml penicillin,10 mg/ml streptomycin, 25µg/ml 
amphotericin-B) were purchased from Gibco, USA. Keratinocyte growth 
medium-2 (KGM-2) was purchased from PromoCell (Heidelberg, Germany). 
Fungizone (amphotericin-B), RPMI-1640 were purchased from Invitrogen 
(Loughborough, UK). All other chemicals were obtained locally and were of 
analytical reagent grade. 
2.2. Characterization of nanoparticles 
ZnO nanoparticles were suspended in complete culture medium (cell culture 
medium supplemented with 10% FBS) at a concentration of 80 µg/ml and 
probe sonicated (Sonics & Material Inc., New Town, CT, USA) at 30 watt for 
10 min (2.5 min on and 30 sec off). 
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2.2.1. Dynamic light scattering 
Size and zeta potential were determined using dynamic light scattering and 
phase analysis light scattering in a Zetasizer Nano- ZS, Model ZEN3600 
equipped with 4.0mW, 633nm laser (Malvern instruments Ltd., Malvern, UK).  
2.2.2. Transmission electron microscopy 
Samples for transmission electron microscopy (TEM) analysis were 
prepared by drop coating ZnO nanoparticles suspension (8µg/ml in Milli-Q) 
on carbon-coated copper grids. The films on the TEM grids were allowed to 
dry prior to measurement. TEM measurements were performed on a JEOL 
model 1200EX instrument operated at an accelerating voltage at 120 kV. 
2.3. Cellular uptake of nanoparticles 
2.3.1. Flow cytometry 
The uptake of nanoparticles using flow cytometry was carried out according 
to the method developed by Suzuki et al (2007). 2 x 105 cells/ well were 
seeded in 6-well cell culture plates. After 24 h of seeding, the cells were 
exposed to ZnO nanoparticles (8, 14, 20µg/ml) for 6 h. After exposure, the 
culture medium containing nanoparticles was removed and the cells were 
harvested using 0.05% trypsin. They were then centrifuged at 250g for 5min. 
The supernatant was discarded and the pellet was re-suspended in 0.5 ml of 
PBS. The uptake of nanoparticles was determined by a flow cytometer 
(FACS Canto™ II, BD Biosciences, San Jose, CA, USA) equipped with a 
488 nm laser. 
2.3.2. Electron microscopy 
Transmission electron microscopy (TEM) and back-scattered electron 
scanning electron microscopy (BSE-SEM) were conducted on ZnO 
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nanoparticles exposed cells to determine the cellular uptake of nanoparticles 
according to the modified protocol of Bastian et al (2009). After 6 h 
exposure, the cells were washed with 1X PBS, harvested with 0.25% trypsin 
and fixed with 0.5% glutaraldehyde- 2% paraformaldehyde buffered in 0.1M 
sodium cacodylate at room temperature. The cells were then post-fixed in 
1% osmium tetroxide and dehydrated through a series of alcohol (20% to 
70%), stained in 0.5% uranyl acetate, followed by dehydration (90% and 
100%) and embedded in epoxy resin (British BioCell International, Cardiff, 
Wales, UK). Ultrathin (60-90 nm) and semithin (200-500nm) sections were 
cut conventionally using a Reichert-Jung ultramicrotome (Vienna, Austria). 
The ultrathin sections were mounted on carbon-coated nickel grids (Agar 
Scientific) and examined on a Jeol-1200 EX transmission electron 
microscope (Jeol, Tokyo, Japan). 
For SEM analysis, the semithin sections were mounted on glass slides and 
each slide was carbon coated. Specimens were viewed under field emission 
SEM (FEI, Quanta 400, Oregon, USA) using back scattered electrons at 20 
KeV. 
2.4. Cytotoxicity assays 
2.4.1. MTT assay 
This assay was conducted to assess the mitochondrial activity of cells. 3-4, 
5-Dimethyl thiazol-2-yl 2,5-diphenyl tetrazolium  bromide (MTT), is a yellow 
dye which is converted into formazan, a violet compound by the activity of 
the mitochondrial enzyme succinate dehydrogenase. MTT assay was done 
according to method of Mosmann (1983). Cells (10,000/well in 100µl 
medium) were seeded in 96 well plate and allowed to adhere overnight. 
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Medium was aspirated and cells were incubated at 37oC for different time 
periods with nanoparticles and for 4 h with MTT dye (5mg/ml in PBS). The 
reaction mixture was carefully aspirated and the resulting formazan crystals 
were solubilized by adding 200µl dimethylsulphoxide. After 10min, 
absorbance was read at 530nm in a SYNERGY-HT multiwell plate reader, 
Bio-Tek (USA) using KC4 software. The untreated sets were also run 
parallel under identical conditions and served as control.  
2.4.2. Neutral red uptake assay 
The neutral red uptake assay was done by the method of Borenfreund and 
Puerner (1985) to determine cell viability. Cells (10,000/well in 100µl 
medium) were seeded in 96 well plates and allowed to adhere overnight. 
Medium was aspirated and cells were incubated at 37oC for different time 
periods with nanoparticles. Thereafter, the medium was discarded and 100µl 
of neutral red dye (50 µg/ml in serum free medium) was added to each well. 
After incubation at 37oC for 3 h, cells were washed with a solution of 0.5% 
formaldehyde and 1% CaCl2.  The dye taken up by cells was then dissolved 
in a medium containing 50% ethanol and 1% acetic acid in Milli-Q water. 
Absorbance was taken at 540nm in a SYNERGY-HT multiwell plate reader, 
Bio-Tek (U.S.A.) using KC4 software. The untreated sets were also run 
parallel under identical conditions and served as control. 
2.4.3. Lactate dehydrogenase (LDH) release assay 
LDH activity in extracellular medium due to membrane damage was 
assessed by Tox-7 in vitro toxicology assay kit (Sigma–Aldrich Inc., St. 
Louis, MO, USA) using manufacturer’s protocol. The assay is based on the 
reduction of NAD by the action of LDH. The resulting reduced NAD (NADH) 
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is utilized in the stoichiometric conversion of a tetrazolium dye. The resulting 
colored compound is measured spectrophotometrically. 
Cells (10,000/well in 100µl medium) were seeded in 96 well plate and 
allowed to adhere overnight. Medium was aspirated and cells were 
incubated at 37oC for different time periods with nanoparticles. After 
completion of exposure period, the culture plates were centrifuged at 250g 
for 4 min. The supernatant of each well was transferred to a fresh flat bottom 
96-well culture plate. LDH assay mixture was prepared by mixing equal 
amounts of LDH assay substrate, cofactor and dye solutions. This assay 
mixture was added in an amount equal to 2X the volume of supernatant 
present in each well. The plate was incubated in dark at room temperature 
for 20 min and the reaction was terminated by the addition of 1/10 volume of 
1N HCl. The untreated cells were also run parallel under identical conditions 
and served as control. The resulting coloured compound was measured 
spectrophotometrically at 490nm in SYNERGY-HT multiwell plate reader, 
Bio-Tek (USA) using KC4 software. 
2.5. Assays for oxidative stress markers 
2.5.1. Reactive oxygen species (ROS) measurement 
The level of intracellular ROS generation was estimated by the method of 
Wan et al (1993) using 2, 7-dichlorofluorescein diacetate dye (DCFDA; 
Sigma, St Louis, MO, USA). DCFDA is transported across the cell 
membrane and deacetylated by esterases to form the non-fluorescent 2’,7’-
dichlorfluorescein (DCFH). This compound is trapped inside the cells and 
oxidised to fluorescent product DCF by various ROS.  
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Cells (10,000/well in 100µl medium) were seeded in 96 well black bottom 
plate and allowed to adhere overnight. Medium was aspirated and cells were 
incubated at 37oC for different time periods with nanoparticles. After 
exposure, the cells were washed twice with PBS and incubated with DCFDA 
dye (20µM) for 30 min at 37oC. The reaction mixture was then replaced by 
200µl of PBS and fluorescence intensity was measured in a SYNERGY-HT 
multiwell plate reader, Bio-Tek (USA) using KC4 software at excitation and 
emission wavelengths of 485nm and 528nm respectively. The qualitative 
analysis of ROS generation was done using a microscope with fluorescence 
attachment (DMLB, Leica, Germany).  
2.5.2. Lipid peroxidation assay 
The levels of lipid peroxides were estimated by Lipid Hydroperoxide Assay 
Kit (Cayman’s Chemicals Kit, MI, USA) according to manufacturer’s protocol.  
A. Background:  
The kit measures the hydroperoxides directly utilizing the redox reactions 
with ferrous ions. Hydroperoxides are highly unstable and react readily with 
ferrous ions to produce ferric ions. The resulting ferric ions are detected 
using thiocyanate as the chromogen. 
B.  Kit contents 
(i) Extract R: crystalline solid provided for extraction of samples. A saturated 
solution of Extract R in methanol was prepared. 
(ii) Lipid hydroperoxide standard: 50 µM ethanolic solution of 13-
hydroperoxyoctadecadienoic acid (13-HpODE). 
(iii) FTS reagent 1: 4.5mM ferrous sulphate in 0.2M hydrochloric acid. 
(iv) FTS reagent 2: 3% methanolic solution of ammonium thiocyanate. 
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C. Procedure:  
The cells from 75cm2 culture flask were scraped and sonicated (10Watt for 5 
sec) in chilled de-ionized water (1ml) and 500µl transferred to the glass test 
tubes. Equal volume (500µl) of Extract R saturated methanol was added to 
each tube and vortexed. 1ml chloroform was added to this mixture, mixed 
thoroughly by vortexing, centrifuged at 1500xg/ 0oC for 5min and the bottom 
chloroform layer was carefully collected. 500µl of this chloroform extract was 
transferred to fresh glass test tubes and 450µl of chloform-methanol solvent 
mixture (1:1) was added to each sample tube. Chromogen was prepared by 
mixing equal amounts of FTS reagent 1 and FTS reagent 2 and 50µl of 
freshly prepared chromogen was added to each assay tube. After 5min, the 
absorbance was measured spectrophotometrically at 500nm in SYNERGY-
HT multiwell plate reader, Bio-Tek (USA) using KC4 software. In this assay, 
a range of different concentrations (0-100nmol) of 13-HpODE were used to 
produce a standard curve. 
2.5.3. Catalase assay 
The catalase activity was estimated by Catalase Assay kit (Cayman’s 
Chemicals Kit, MI, USA) according to manufacturer’s protocol.  
A. Background:  
The method is based on the peroxidatic activity of catalase enzyme in which 
low molecular weight alcohols (e.g. methanol) serve as specific substrates 
for catalase. The product- formaldehyde is measured colorimetrically with 4-
amino-3-hydrazino-5-mercapto-1,2,4-trizole (Purpald) as the chromogen.  
B.  Kit contents 
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(i) Assay buffer (10X): Diluted to 1X (100 mM potassium phosphate, pH 7.0) 
with HPLC-grade water before use. 
(ii) Sample buffer (10X): Diluted to 1X (25 mM potassium phosphate, pH 7.5 
containing 1mM EDTA and 0.1% BSA) with HPLC-grade water before use. 
(iii) Formaldehyde standard: 4.25 M formaldehyde. 
(iv) Catalase: The lyophilized catalase is reconstituted by adding 2ml of 
sample buffer to the vial and vortexing. 100µl of reconstituted enzyme is 
diluted with 1.9ml of sample buffer before use. 
(v) Methanol 
(vi) Hydrogen peroxide: 8.82 M solution of hydrogen peroxide. 40µl of 
hydrogen peroxide diluted with 9.96ml of HPLC-grade water before use. 
(vii) Purpald: Solution of Purpald in 0.5M hydrochloric acid. 
C. Procedure: 
The cells from 75cm2 culture flask were scraped and sonicated (10 Watt for 
5 sec) in 1ml of sample buffer. The sonicated cells were centrifuged at 
1500xg/ 4oC for 5min and the supernatant was collected. 20µl of each 
sample along with assay buffer (100µl) and methanol (30µl) was added to 
the wells of a 96 well plate. At the same time, a range of different 
concentrations (0-75µM) of formaldehyde were used to produce a standard 
curve and 20µl of diluted catalase enzyme in two wells was used as the 
positive control. The reaction in each well was initiated by adding 20µl of 
hydrogen peroxide to each well for 20 min at room temperature. Purpald 
(30µl) was added to each well and the plate was incubated for 10min at 
room temperature. Following incubation, the absorbance was read at 540nm 
in SYNERGY-HT multiwell plate reader, Bio-Tek (USA) using KC4 software. 
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2.5.4. Superoxide dismutase (SOD) assay 
The SOD activity was estimated by Superoxide Dismutase Assay Kit 
(Cayman’s Chemicals Kit, MI, USA) according to manufacturer’s protocol.  
A. Background:  
This assay utilizes a tetrazolium salt for detection of superoxide radicals 
generated by xanthine oxidase and hypoxanthine. One unit of SOD is 
defined as the amount of enzyme needed to exhibit 50% dismutation of the 
superoxide radical. 
B.  Kit contents 
(i) Assay buffer (10X): Diluted to 1X (50mM tris-HCl, pH 8, containing 0.1mM 
diethylenetriaminepentaacetic acid (DTPA) and 0.1M hypoxanthine) with 
HPLC-grade water before use. 
(ii) Sample buffer (10X): Diluted to 1X (50mM tris-HCl, pH 8) with HPLC-
grade water before use. 
(iii) Radical detector: Contains a solution of tetrazolium salt. Prior to use, 
50µl of radical detector is diluted with 19.95ml of 1X assay buffer. 
(iv) SOD standard: Contains a solution of bovine erythrocyte SOD. 
(v) Xanthine oxidase: Prior to use, 50µl of the enzyme is diluted with 1X of 
1.95ml of sample buffer. 
C. Procedure: 
The cells from 75cm2 culture flask were scraped and sonicated (10Watt for 5 
sec) in 1ml of 20mM HEPES buffer, pH 7.2, containing 1 mM EGTA, 210 
mM mannitol and 70mM sucrose. The sonicated cells were centrifuged at 
1500xg/ 4oC for 5min and the supernatant was collected. 10µl of each 
sample along with the diluted radical detector (200µl) was added to the wells 
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of a 96 well plate. The reaction was started by adding 20µl of diluted 
xanthine oxidase to each well. The plate was incubated on a shaker for 20 
min at room temperature. The absorbance was read at 450 nm in 
SYNERGY-HT multiwell plate reader, Bio-Tek (USA) using KC4 software. In 
this assay, a range of different concentrations (0-200µl) of SOD were used 
to produce a standard curve. 
2.5.5. Glutathione (GSH) estimation 
Glutathione content was measured according to the method of Ellman 
(1959). 
Reagents: 
(a) 0.2 M Phosphate PO4 buffer, pH 8 
(b) 0.01 % DTNB in PO4 buffer (freshly prepared) 
(c) 0.02 % Glutathione (freshly prepared) 
(d) 5 % Trichloroacetic acid (TCA) 
The cells from 75cm2 culture flask were scraped and sonicated (15Watt for 
10 sec) in 3ml of 1X PBS. 1ml of this cell homogenate was deproteinized by 
addition of an equal volume of 10% TCA and incubated at room temperature 
for 0.5h. It was then centrifuged at 2,500 rpm for 15min. To 0.5ml of 
supernatant, 2.5ml of DTNB reagent was added and kept for incubation for 
15min. It was then read at 412nm. Different concentrations of glutathione 
were taken as standard. From the standard curve, glutathione content was 
calculated and expressed as µmole/mg of protein. 
2.6. Cell viability assay using Trypan blue 
Assessment of cell viability was made for all experiments of the Comet 
assay as per the guidelines of Tice et al (2000). Cell viability was assessed 
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by the trypan blue dye exclusion method (Phillips 1973). The principle of the 
assay is based on the fact that the live (viable) cells have an intact cell 
membrane that excludes dyes such as trypan blue, while the dead (non 
viable) cells have a compromised (permeable) cell membrane and hence 
take up the dye. Live cells appear shiny yellow and dead cells appear blue 
when observed under a bright field microscope.  
10µl of cell suspension (~106 cells/ml) was added to 10µl trypan blue dye 
(0.4%) and mixed well. After 1-2min, 20µl of the mixture was loaded on to a 
clean haemocytometer and observed under bright field microscope under a 
10X objective with a total magnification of 100X. 
The viability (%) was calculated as follows: 
Viability (%) = Total number of cells – stained (blue) cells X 100  
    Total number of cells 
2.7. Single cell gel electrophoresis (SCGE) assay/ Comet assay 
DNA damage was assessed using the Comet assay for in vitro studies 
employing cell line and for in vivo studies in different organs and tissues of 
mouse. 
2.7.1. Standard alkaline Comet assay 
Slides were prepared by the method as described (Singh et al. 1988) and 
modified (Bajpayee et al. 2005) in previous studies. Single cell suspension 
containing ~20,000 cells of interest in 100µl medium 1XPBS was mixed (1:1) 
with 1% low melting point agarose (LMPA). 80µl of the suspension was 
layered on to a microscopic slide pre-coated with 1% normal melting 
agarose. A coverslip was placed on the slide to ensure that the gel was 
evenly spread, and the slide was kept on ice to allow the gel to solidify. A 
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third layer of LMPA was added and again allowed to solidify on ice. 
Duplicate slides were prepared for each sample. The cover slips were 
removed and the slides immersed in freshly prepared and chilled lysis 
solution (2.5M NaCl, 100mM EDTA, 10mM Tris, pH10) with 1% Triton X-100 
being added just before use (10% DMSO was also added when preparing 
slides from whole blood). The slides were kept in lysis solution overnight at 
4oC. The slides were subjected to DNA unwinding for 20min and 
subsequently electrophoresis was performed at 0.7V/cm and 300mA at 4oC 
for 25min in freshly prepared electrophoresis buffer (1mM EDTA sodium salt 
and 300mM NaOH). All the steps were performed under dim light. After 
electrophoresis, the excess alkali was neutralized with Tris buffer (0.4M, 
pH7.5), and slides were stained with 75µl ethidium bromide (20µg/ml).  
Slides were scored at a final magnification of 400X using an image analysis 
system (Kinetic Imaging, Liverpool, U.K.) attached to a microscope (Leica, 
Germany) equipped with fluorescence attachment and appropriate filter 
(N2.1). The Comet parameters used to measure DNA damage in the cells 
were % tail DNA (fraction of DNA in the tail) and Olive tail moment (OTM; 
arbitrary units, the product of the distance of DNA migration from the body of 
nuclear core and the total fraction of DNA in the tail; figure 2.1). As per the 
Comet assay guidelines (Hartmann et al. 2003; Tice et al. 2000) images 
from 50 cells (25 cells /replicate slide) were scored for in vitro studies while 
100 cells (50 cells/ replicate slide) were scored for in vivo studies. 
2.7.2. Fpg-modified Comet assay 
To determine the oxidative DNA damage, the slides were immersed in two 
changes of enzyme buffer (40mM HEPES, 0.1M KCl, 0.5mM EDTA and 0.2 
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mg/ml bovine serum albumin (pH 8.0)) after lysis. Gels were then covered 
with 30µl Fpg enzyme (1:3000 dilution in enzyme buffer) and a cover slip 
and incubated in a humidified chamber for 30min at 37oC (Smith et al. 2006). 
The slides were processed as in the standard alkaline Comet assay. 
 
 
 
 
 
 
 
                         
 
Figure 2.1. Cell marked with comet parameters. 
 
2.8. Detection of apoptosis  
2.8.1. AnnexinV/PI staining 
Annexin V-FITC/PI staining was carried out by Annexin V-FITC apoptosis 
detection kit (Sigma, St Louis, MO, USA) as per the manufacturer’s protocol 
using flow cytometry.   
A.  Kit contents 
(i)  Annexin V-FITC conjugate: 50 µg/ml in 50 mM Tris-HCl, pH 7.5 
containing 100 mM NaCl.  
(ii) Propidium Iodide (PI) solution: 100 µg/ml in 10 mM potassium phosphate 
buffer, pH 7.4, containing 150 mM NaCl 
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(iii) 10X binding buffer: 100 mM HEPES/NaOH, pH 7.5 containing 1.4 M 
NaCl. A working solution of 1X was prepared by diluting 1 part of stock with 
9 parts of distilled H2O. 
B. Harvesting and staining 
Cells were harvested with 0.05% trypsin and placed into a round bottom 
tube. They were centrifuged at 300xg for 5min at room temperature (20-
25°C). Supernatant was discarded, pellet resuspended in cold PBS and 
centrifuged again at 300xg for 5min. The pellet was resuspended in binding 
buffer at a concentration of 1.0 x 106 cells/ml. 500µl of the cell suspension 
was transferred to 12 x 75 mm test tube. 5µl of Annexin V-FITC and 10µl of 
PI, was added to the tube and incubated for 15min in dark at room 
temperature. Analysis was done immediately using flow cytometer. 
C. Flow cytometric analysis 
Cells were analyzed using FACS CantoTM II (BD Biosciences, San Jose, CA, 
USA). The events were recorded at wavelengths of 488nm (excitation) and 
600nm (emission) as red fluorescence and 520nm (emission) for green 
fluorescence. Data was acquired using FACSDiva software (V6.1.2, BD 
Biosciences). A minimum of 10,000 events per sample was analyzed. 
Quadrant analysis of dot plot was done using FACSDiva software (V6.1.2, 
BD Biosciences) so as to estimate percentage of cells undergoing early and 
late apoptosis. 
2.8.2. Hoechst staining 
Apoptotic nuclear morphology was also assessed using Hoechst 33342 
(Sigma, St Louis, MO, USA). Cells were fixed with 4% paraformaldelyde at 
room temperature for 30min, washed with PBS and stained with 2µg/ml 
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Hoechst 33342 at 37°C for 10min. The cells were washed and the 
morphology was observed by fluorescence microscopy (DMLB, Leica, 
Germany) at 200X.  
2.9. Assessment of mitochondrial membrane potential 
Mitochondrial membrane potential (∆Ψm) was detected with fluorescent 
probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine 
iodide (JC-1; Molecular probes, USA), which exists predominantly in green 
fluorescent monomeric form in cells with depolarized mitochondria and in 
aggregate form (reddish orange) in cells with polarized mitochondria. Cells 
exposed to ZnO nanoparticles were harvested with 0.05% trypsin and 
placed into a round bottom tube. They were centrifuged at 300xg for 5min at 
room temperature (20-25°C). Supernatant was discarded, pellet 
resuspended in cold PBS and centrifuged again at 300 x g for 5min. The 
cells were incubated with 10 µM JC-1 dye for 15min at 37oC, washed with 
PBS and re-suspended in PBS at a concentration of 1.0 x 106 cells/ml. Cells 
were analyzed using FACS CantoTM II (BD Biosciences, San Jose, CA, 
USA) and the events were recorded at wavelengths of 488 nm (excitation) 
and 600nm (emission) as red fluorescence and  520nm (emission) for green 
fluorescence. Data was acquired was using FACSDiva software (V6.1.2, BD 
Biosciences). A minimum of 10,000 events per sample was analyzed. 
Quadrant analysis of dot plot was done using FACSDiva software (V6.1.2, 
BD Biosciences).  
For qualitative analysis, the cells were imaged for green and red 
fluorescence using a microscope with fluorescence attachment (DMLB, 
Leica, Germany) at 200X. 
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2.10. Western blot analysis 
Western blotting was done to assess the expression levels of proteins of 
interest. 
Protein extraction  
For in vitro experiments, cells treated with ZnO nanoparticles were collected 
in chilled PBS by scraping and pelleted by centrifugation at 500xg for 10min. 
The cell pellet was then washed with PBS and 150µl of CelLyticTM M Cell 
Lysis Reagent (Sigma, St. Louis, MO, USA) supplemented with Na-
orthovanadate, Na-fluoride, protease inhibitor cocktail was added to it. The 
cell pellet was vortexed gently and kept for 10min in ice. Finally, the lysed 
cells were centrifuged at 10,000xg for 5 min and the supernatant containing 
the solublised protein collected and stored at 80oC. 
For in vivo samples, the tissue was homogenized with Polytron PT 1600 E 
(KINEMATICA, Switzerland) in CelLyticTM M Cell Lysis Reagent (25µl/mg of 
tissue; Sigma, St. Louis, MO, USA) supplemented with Na-orthovanadate, 
Na-fluoride, protease inhibitor cocktail and subsequently processed as 
described above.  
Protein estimation  
The total protein concentration was measured by the method of Bradford 
(1976).  The assay is based on an absorbance shift in the dye coomassie 
(red colour) which changes and stabilizes into coomassie blue by the binding 
of protein. The characteristic blue colour has a maximum absorbance at 
595nm which is proportional to the amount of bound dye, and thus to the 
concentration of protein present in the sample. In this assay a range of 
different concentrations (0-100µg/ml) of bovine serum albumin were used to 
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produce a standard curve. The optical densities of BSA standards and 
unknown samples were read at 595nm on a SYNERGY-HT multiwell plate 
reader, Bio-Tek (U.S.A.) using KC4 software. 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
The 10% resolving gel solution (30% acrylamide, 1.5M Tris-Cl (pH 8.8), 10% 
SDS, 10% ammonium persulphate and 20µl TEMED) was mixed thoroughly 
and poured into the preset casting assembly (Bio-Rad Laboratories, 
California, USA) followed by the 5% stacking gel solution (30% Acrylamide, 
1.5M Tris-Cl (pH 6.8), 10% SDS, 10% ammonium persulphate and 20 µl 
TEMED). Gel was placed in the electrophoresis tank as instructed by the 
manufacturer and bathed in gel running buffer (0.125M Tris base, 1M 
Glycine, 0.5% SDS). 2X Laemmeli buffer (4% SDS, 20% glycerol, 10% 2-
mercaptoethanol, 0.004% bromphenol blue, 0.125 M Tris HCl, pH6.8) was 
added to the whole cell lysate proteins in equal amount and the samples 
were heated at 95oC for 5 min. 4 µl of the pre-stained protein ladder 
(PageRulerTM Plus; Fermentas Life Sciences, USA) and denatured protein 
samples (40µg) were loaded into the appropriate well. The gel was run at a 
constant voltage of 100V until the dye from Laemmeli buffer reached the 
lower window on the cassette. 
Electro-transfer of protein on nitrocellulose membrane 
After separation of proteins on the SDS-PAGE gel, proteins were electro 
transferred to a nitocellulose membrane (Pall Corporation, Florida, USA). 
The nitrocellulose membrane was equilibrated in transfer buffer (192 mM 
glycine, 25 mM Tris base and 20%methanol). The membrane was placed 
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next to the gel and sandwiched between sponges. All were clamped tightly 
together after ensuring no air bubbles have formed between the gel and 
membrane. The sandwich was submerged in transfer buffer in an 
electrotransfer apparatus (Bio-Rad Laboratories, California, USA). The 
power supply was connected at a constant voltage of 100V for 1h. The 
negatively-charged proteins travel towards the positively-charged electrode, 
but the membrane stops them and binds them. The membrane was then 
blocked with blocking buffer. 
Incubation with antibodies and detection of protein bands 
TBST buffer was prepared by adding 0.05% Tween-20 in Tris buffer saline 
(10mM Tris base, 150mM Sodium chloride; pH7.2). The non-specific binding 
sites were blocked with blocking buffer - 5% non fat milk in TBST buffer. 
After 1.5h of blocking at room temperature on a rocking platform, the 
membrane was probed with anti-human primary antibodies (1:1000 diluted in 
TBST) against β-actin, JNK, phospho-JNK, ERK1/2, phospho-ERK1/2, p38, 
phospho-p38, caspase-9, p53, phospho-p53 (Ser15), Bcl2, Bax, nuclear 
factor kappa β (NF-kβ), (Cell Signaling Technology, Danvers, MA, USA) for 
1h at room temperature followed by overnight incubation at 4oC. The 
membranes were then washed with TBST thrice (4min each time). After 
washing, the membrane was incubated with secondary anti-primary antibody 
conjugated to horseradish peroxidase (Calbiochem,USA) for 1h at room 
temperature. The membrane was again washed thoroughly with TBST buffer 
and antigen antibody complex signals were detected using an enhanced 
chemiluminescence detection system according to the manufacturer’s 
protocol (Super Signal West Pico Chemiluminescent Reagent, Pierce, 
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Rockford, IL, USA). Relative expression of each protein was determined by 
densitometric analysis using Scion Image program (Scion Corporation, 
Fredrick, MD, USA). β-actin served as protein loading control. 
2.11. In vivo studies 
2.11.1. Animals and treatment  
All animal-handling procedures were carried out following the regulations of 
Institutional Animal Ethics Committee and with their prior approval for using 
the animals. Male Swiss albino mice (∼6-week-old, 20 ± 2g) were obtained 
from the Indian Institute of Toxicology Research (Lucknow, India) animal 
breeding colony and were housed in a 12-h day and light cycle environment 
with ad libitum availability of diet and water, at the controlled temperature of 
23 ± oC, humidity of 55 ± 5%. The animals were maintained. The animals 
were divided into 3 groups containing 25 mice each: Group 1- vehicle control 
(water); Group 2- ZnO nanoparticles (300mg/Kg body weight); Group 3- ZnO 
nanoparticles (50mg/Kg). The animals were treated daily through gavage for 
14 consecutive days according to the fixed dose procedure OECD Guideline 
420 (OECD 2001).  
All animals were weighed at the beginning and end of each treatment. After 
the treatments, the animals were sacrificed by cervical dislocation. Organs 
were taken out immediately for isolation of single cells. 
2.11.2. Zn content analysis in tissues 
Approximately 1g of the tissue from liver, kidney and brain were taken in a 
100ml conical glass flask. Each sample was solubilised by the addition of 2 
ml concentrated nitric acid and left overnight. After 24h, 5ml of concentrated 
nitric acid and perchloric acid mixture (6:1) was added to each sample and 
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heated at 80-90oC until the solutions were colourless and clear.The 
concentrated solutions were diluted to 5ml with 1% nitric acid. The Zn 
content was analyzed by an atomic absorption spectrophotometer (ZEEnit 
700 P, Analytikjena, Germany). Before analysis, the atomic absorption 
spectrophotometer (AAS) was calibrated every time by running at least three 
standard concentrations (0.25, 0.5 and 1 mg/L) of zinc. 
2.11.3. Biochemical assays in serum 
The serum was obtained by centrifugation of the whole blood at 3000 rpm 
for 15min. The serum biochemical levels including alanine aminotransferase 
(ALT), alkaline phosphatase (ALP), bilirubin, creatinine, blood urea nitrogen 
were assayed by an automated haematology analyzer (Bayer, USA). 
Standard controls were run before each determination. 
2.11.4. Lipid peroxidation (LPO) assay 
A 10% homogenate was made in ice cold buffer comprising 0.1M Na2HPO4, 
0.1M NaH2PO4 and 0.1M KCl, using a Polytron PT 1600 E (KINEMATICA, 
Switzerland). The homogenate was then centrifuged at 9000xg for 10min 
and the supernatant was used for the enzymatic assay. 
LPO was measured using the method of Utley et al (1976) by estimating 
malondialdehyde (MDA) formed with 2-thiobarbituric acid (TBA). An aliquot 
of homogenate (10% w/v) was taken in a test-tube and incubated for 1h at 
37oC in water bath with constant shaking. The reaction was terminated by 
the addition of 1ml of chilled 10% Trichloroacetic acid (TCA) (w/v). The 
control tubes received TCA prior to the start of incubation. The contents 
were then centrifuged at 2000g for 10min and 1ml of clear supernatant was 
withdrawn and mixed with 1ml of TBA (0.67% w/v) and kept in a boiling 
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water bath for 10min. The intensity of developed colour was measured at 
535nm after dilution with 1ml of water. The results were expressed as 
nanomoles of MDA formed per hour per g tissue. 
2.11.5. Histopathology 
The organs (liver, kidney) from control and treated mice were fixed in 10% 
formalin for 24-48h at room temperature (RT). The tissue slices from these 
organs were dehydrated through 50%, 70%, 80%, 90% alcohol, followed by 
3 changes of 100% alcohol, 1 h each. The tissue slices were kept in 
chloroform, 2 changes of 1 h each and then for 1.5 h at last. They were then 
dipped in molten paraffin wax, 2 changes for 1.5 hr each and then 
embedded in paraffin wax in a steel mould. The prepared paraffin tissue 
blocks were stored at RT until used for cutting sections. 
From the paraffin-embedded tissue blocks 5-8µm thick sections were cut 
using microtome and floated in 40°C water bath containing distilled water. 
The sections were mounted onto glass slides. The slides were allowed to dry 
overnight and stored at RT until used for staining. 
The paraffin embedded sections were dewaxed in xylene and rehydrated by 
passage through gradient alcohol series. They were stained with Harris’s 
haematoxylin for 5 min and washed in running tap water followed by acid 
alcohol wash for 5-10 sec. After washing with tap water, sections were 
rinsed with ammonia water. Sections were then stained with 1% eosin for 30 
sec and washed in tap water for 15-30 sec. The sections were then 
dehydrated through alcohol, cleared in xylene and mounted in DPX. The 
stained sections were then examined by light microscopy for the 
histopathological changes. 
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2.11.6. TUNEL assay 
Principle:  
In situ detection of apoptosis was performed by terminal deoxynucleotide-
transferase (TdT)-mediated dUTP nick end labeling (TUNEL) using a “In Situ 
Cell Death Detection Kit, Fluorescein” (Roche, UT, USA). Cleavage of 
genomic DNA during apoptosis may yield double-stranded, low molecular 
weight DNA fragments (mono- and oligonucleosomes) as well as single 
strand breaks (“nicks”) in high molecular weight DNA. Those DNA strand 
breaks can be identified by labeling free 3’-OH termini with modified 
nucleotides in an enzymatic reaction. DNA strand breaks are labelled by 
Terminal deoxynucleotidyl transferase (TdT), which catalyzes polymerization 
of labelled nucleotides to free 3’-OH DNA ends in a template-independent 
manner (TUNEL-reaction). Fluorescein labels incorporated in nucleotide 
polymers are detected and quantified by fluorescence microscopy.  
 
 
Procedure:  
After de-paraffinization and rehydration, paraffin embedded sections were 
incubated in permeabilization solution (0.1% Triton X-100, 0.1% sodium 
citrate, freshly prepared) for 2min on ice. After washing with PBS, the area 
around the section was dried and 50µl of TUNEL reaction mixture (5µl 
deoxynucleotide-transferase enzyme in 45µl labeled thymidine solution) was 
added on each section. The slides were incubated in a humidified 
atmosphere for 60min at 37°C in the dark. The slides were rinsed 3 times 
with PBS and counterstained with Hoechst 33258 (Molecular probes) 
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nuclear stain and mounted in antifade mountant. The coverslips were sealed 
and observed under fluorescent microscope. Then, stained cells were 
visualized using a microscope with fluorescence attachment (DMLB, Leica, 
Germany). 
2.12. Statistical analysis 
Appropriate statistical methods [Student’s t-test, one way analysis of 
variance (ANOVA)] were employed for data analysis and have been 
described in the relevant chapters. Prior to analysis, homogeneity of 
variance between treatment and normality assumption of data were tested. 
p<0.05 was considered significant. 
 
 
 
 
 
 
 
 
 
 
 
                               
 
89 
 
                                                CHAPTER – 3 
 
 
 
 
 
 
 
 
Toxic responses to ZnO nanoparticles 
in human epidermal cells 
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3.1. Introduction 
Increased consumer demands in conjunction with rapid technological 
advances have resulted in an intensive expansion of nanotechnology 
applications all over the world. However, it has raised concerns with the 
public as well as in the scientific community regarding the unanticipated and 
adverse affects of nanoparticles on human health and the environment.  
This widespread use of nanotechnology may expose humans to 
nanoparticles through different routes such as- oral, dermal and inhalation 
(Nel et al. 2006). Out of all these possible routes, the skin may serve as the 
first portal of entry for these nanoparticles either directly or indirectly through 
intercellular, trans-cellular or trans-appendageal routes (Baroli 2009; 
Crosera et al. 2009). This high probability of nanoparticle-skin contact has 
raised the debate on nanoparticle-skin penetration and subsequent 
interaction with skin cells yielding a few studies on the topic (Cross et al. 
2007; Wu et al. 2009). However, the outcomes of these studies are 
contradictory and inconclusive. Some of these studies report the inability of 
nanoparticles to pass through the protective skin barrier (Cross et al. 2007; 
Gamer et al. 2006; Schulz et al. 2002) while others have shown the possible 
absorption of nanoparticles with diverse physicochemical properties through 
cutaneous barrier (Baroli et al. 2007; Ryman-Rasmussen et al. 2006; 
Sonavane et al. 2008; Wu et al. 2009; Zhang et al. 2008).  
Furthermore, it cannot be ruled out that the stratum corneum barrier may be 
compromised in many conditions like abrasions, wounds, burns, pathological 
alterations (psoriasis; atopic dermatitis), prolonged exposure to chemicals, 
detergents, skin flexures etc (Baroli 2009). There is evidence that 
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nanoparticle penetration/permeation is facilitated by these breaches in skin 
integrity (Kuo et al. 2009; Mortensen et al. 2008; Nielsen et al. 2007; 
Oberdorster et al. 2005; Zhang and Monteiro-Riviere 2008). Larese et al. 
(2009) suggested an increased dermal penetration of silver nanoparticles 
associated with damaged skin in vitro in Franz diffusion cells with full 
thickness human skin. Similar observations were made by Trop et al. (2006) 
following the use of nanosilver coated dressings in case of extensive burns. 
Skin flexions facilitating nanoparticles uptake has also been reported (Rouse 
et al. 2008; Tinkle et al. 2003). 
ZnO nanoparticles are one of the widely used nanoparticles in cosmetics 
and sunscreens as they do not scatter visible light. This makes them 
transparent and more aesthetically acceptable compared to their larger 
opaque counterparts (Cross et al. 2007). Due to high possibilities of 
nanoparticle-skin penetration and subsequent interactions make it necessary 
to evaluate the potential adverse effects of nanoparticles on human skin 
cells.  
Therefore, the aim of the present study was to assess the effects of ZnO 
nanoparticles in human skin cells (primary human epidermal keratinocytes 
and A431 cell line). This was done to evaluate the toxicity of ZnO 
nanoparticles on human skin cells as well as to understand if the responses 
observed in the primary human skin cells are similar to that observed in the 
human skin cell line. 
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3.2. Materials and methods 
3.2.1. Cell culture 
3.2.1.1. A431 cell culture 
Human epidermal cell line (A431) obtained from National Centre for Cell 
Sciences, Pune, India was cultured in DMEM supplemented with 10% fetal 
bovine serum, 10ml/l of antibiotic and antimycotic solution at 37oC under a 
humidified atmosphere of 5%CO2/ 95% air. 
3.2.1.2. Isolation and culture of human epidermal keratinocytes 
The study with primary human epidermal keratinocytes was done in 
collaboration with Centre for Skin Sciences, University of Bradford, Bradford. 
Human scalp tissue was obtained with informed consent and local research 
ethics committee approval (Reference number: E01) from a normal healthy 
Caucasian donor (female 66y) after elective plastic surgery. Skin samples 
were collected in RPMI 1640 medium and were processed within 5 h of 
surgery. Epidermal keratinocyte cultures were established as previously 
described by Kauser et al. (2003). Briefly, tissue specimens were washed 
with 0.1 M phosphate-buffered saline (PBS) pH 7.4 containing fungizone 
(12.5 µg/ml), penicillin (500 U/ml) and streptomycin (12.5 µg/ml). Epidermal 
sheets were separated from the underlying dermis after 18 h incubation in 
0.25% trypsin solution at 4°C and dispersed into individual cells. The cells 
were then grown in KGM-2 containing 0.004ml/ml bovine pituitary extract, 
0.125 ng/ml recombinant epidermal growth factor, penicillin (100 U/ml) 
/streptomycin (100 µg/ml) and 2 mM L-glutamine. The cells were incubated 
at 37°C under a humidified atmosphere of 5%CO2/ 95% air and the culture 
medium was changed every second day. 
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3.2.2. Characterization of ZnO nanoparticles 
The particles were characterized by dynamic light scattering and 
transmission electron microscopy (TEM) as described in Chapter 2 (2.2). 
3.2.3. Exposure of cells to nanoparticles 
The cells were plated at a density of 105 cells/ml in a 96 well plate and 12 
well plate for the cytotoxicity assays and Comet assay respectively. They 
were then allowed to attach for 24h before the addition of nanoparticles 
suspension. Stock suspension of ZnO nanoparticles (80 µg/ml) in DMEM (for 
A431cells) and KGM-2 (for primary human epidermal keratinocytes) was 
diluted to different working concentrations. Cells were then exposed to 
different concentrations of ZnO nanoparticles for diverse time periods as per 
the experimental design.  
To determine the cellular uptake of nanoparticles, the cells were seeded in 
cell culture flasks (25cm2) and grown to 70% confluency at 37oC in a 
humidified 5% CO2 environment. The cells were then treated with ZnO 
nanoparticles for 6h. 
For evaluating oxidative stress markers, the cells were cultured in 75cm2 
culture flask and exposed to ZnO nanoparticles for 24h. 
3.2.4. Cellular uptake 
The cellular uptake of nanoparticle in the cells was determined by electron 
microscopy as described in Chapter 2 (2.3.2).  
3.2.5. Cytotoxicity assays 
The cytotoxicity assays viz. MTT, neutral red uptake and LDH release were 
performed as described in Chapter 2 (2.4).  
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3.2.6. Cell morphology 
Cell morphology was assessed following exposure to nanoparticles using a 
Leica DMIL phase contrast microscope (magnification X100). 
3.2.7. Cell viability 
Cells were incubated with ZnO nanoparticles for 6h at different 
concentrations and assayed for viability using Trypan blue dye exclusion 
(Philips 1973) as described in Chapter 2 (2.6). 
3.2.8. Single cell gel electrophoresis/ Comet assay 
The Comet assay was performed as described previously in Chapter 2 
(2.7.1). 
3.2.9. Oxidative stress markers 
The levels of oxidative stress in ZnO nanoparticles exposed cells were 
analysed by measuring lipid peroxidation, glutathione, superoxide dismutase 
and catalase levels as described in Chapter 2 (2.5). 
3.2.10. Statistical analysis 
Results were expressed as mean ± standard error of mean (S.E.M.) and the 
data were analyzed by one way analysis of variance (ANOVA) with Dunnett 
post hoc test to determine significance compared to unexposed control, 
using SPSS v. 16.0 software (SPSS Inc., Chicago, IL, USA). In all cases, p < 
0.05 was considered significant. 
3.3. Results 
3.3.1. Characterization of ZnO nanoparticles 
The mean hydrodynamic diameter and zeta potential of the ZnO 
nanoparticles (80µg/ml) suspension in DMEM (supplemented with 10% FBS) 
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was 273nm and -12.7mV respectively (Figure 3.1A-B), while in KGM-2, it 
was 245nm and −15.8mV (Figure 3.1C-D). 
The average size reported by TEM was 30nm. Figure 3.1E shows a 
representative TEM image recorded from a drop-coated film of ZnO 
nanoparticles. 
3.3.2. Studies with human epidermal skin cells (A431) 
3.3.2.1. Cellular uptake of ZnO nanoparticles 
A431 cells exposed to ZnO nanoparticles (8µg/ml) for 6h showed a 
significant cellular uptake of the nanoparticles and their accumulation in the 
vesicles and nucleus as evident from the TEM microphotographs (Figure 
3.2).  
3.3.2.2. Cytotoxicity of ZnO nanoparticles 
A431 cells were exposed to ZnO nanoparticles (0.008–20µg/ml) for 3, 6, 24 
and 48h and cytotoxicity was determined with MTT assay, LDH release 
assay, and NRU assay. The MTT results demonstrated a concentration and 
time dependent cytotoxicity after exposure to nanoparticles (Figure 3.3A). 
The cytotoxicity was evident even after 3h at the highest concentration 
(20µg/ml). The percentage (%) MTT reduction (relative to control) observed 
after 24h exposure at concentrations 0.8, 5 and 8µg/ml was 91%, 52% and 
25% respectively with a further decrease to 86%, 42% and 9% after 48h 
exposure. The results of NRU assay showed a similar concentration and 
time dependent response with a loss in cell viability at 8-20µg/ml after 24 
and 48h exposure (Figure 3.3B). A significant (p < 0.05) LDH leakage was 
observed at 24h and 48h on exposure to 5, 8 and 20µg/ml ZnO nanoparticle 
concentrations (Figure 3.3C). 
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3.3.2.3. Cell morphology 
A comparative morphology of unexposed cells and ZnO nanoparticles 
exposed cells is shown in figure 3.4. Cells treated with ZnO nanoparticles 
(8µg/ml) for 24h retracted into spherical shape and detached from the 
surface of culture flask forming clusters (Figure 3.4A–D). The changes in 
morphology started becoming visible even after 6h exposure with a few cells 
becoming spherical.  
3.3.2.4. Cell viability 
The cell viability in the Comet assay exceeded 90% for all experimental 
groups (data not shown) before and after the treatment as assessed by 
Trypan blue dye exclusion assay. 
3.3.2.5. Genotoxic potential of ZnO nanoparticles  
A significant induction (p < 0.05) in the DNA damage was observed in cells 
exposed to ZnO nanoparticles for 6h compared to control  as evident by the 
Comet assay parameters i.e. Olive tail moment (arbitrary unit) and tail DNA 
(%) (Table 3.1). 
3.3.2.6. Oxidative stress parameters 
Effect of ZnO nanoparticles on lipid peroxidation 
Lipid peroxidation was examined by measuring hyderoperoxide 
concentration. A significant increase (p<0.05) in hydroperoxide formation 
was observed at all concentrations above 0.008µg/ml of ZnO nanoparticles 
as evident from Figure 3.5A. 
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Effect of ZnO nanoparticles on glutathione level 
Cells exposed to ZnO nanoparticles showed statistically significant (p<0.05) 
depletion of GSH levels at 0.8 and 0.08µg/ml respectively after 24h (Figure 
3.5B). 
Effect of ZnO nanoparticles on catalase activity 
ZnO nanoparticles exposed cells at the highest concentration (0.8µg/ml) 
showed 64% decrease (p < 0.05) when compared to control. Cells exposed 
to 0.08 and 0.008µg/ml of concentrations also exhibited decrease (p < 0.05) 
of 55% and 36% respectively (Figure 3.5C). 
Effect of ZnO nanoparticles on SOD activity 
SOD activity in cells treated with 0.008, 0.08 and 0.8µg/ml ZnO 
nanoparticles was significantly (p<0.05) reduced after 24h of exposure when 
compared to unexposed cells as evident from Figure 3.5D. 
3.3.3. Studies with primary human epidermal keratinocytes 
3.3.3.1. Cellular uptake of ZnO nanoparticles 
The primary human epidermal keratinocytes were treated with ZnO 
nanoparticles (14 µg/ml) for 6h and the cellular uptake of nanoparticles was 
investigated by scanning electron microscope using back scattered electrons 
imaging. Nanoparticle agglomerates with strong BSE signals were visible in 
cells treated with ZnO nanoparticles (Figure 3.6A-B).  
Further confirmation of ZnO nanoparticles internalization into the cells was 
obtained by transmission electron microscopy which revealed nanoparticles 
in the cytoplasm (Figure 3.7A-B) and in the filopodia extending from the cell 
body (Figure 3.7C, High power view).  
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3.3.3.2. Cytotoxicity of ZnO nanoparticles 
The primary human epidermal keratinocytes were exposed to ZnO 
nanoparticles (4-20µg/ml) for 6, 12 and 24h and cytotoxicity was determined 
with the MTT assay which demonstrated a concentration and time 
dependent decrease in the mitochondrial activity (Figure 3.8). The 
cytotoxicity was evident after 6h at the highest concentration (20µg/ml). The 
percentage (%) MTT reduction (relative to control) observed after 12h 
exposure at concentrations 8, 14 and 20 µg/ml was 80%, 72% and 69% 
respectively with a further decrease to 59%, 51% and 31% after 24h 
exposure.  
3.3.3.3. Cell morphology 
The changes in cell morphology on exposure to ZnO nanoparticles (20µg/ml 
for 6h) also corroborated our cytotoxicity results (Figure 3.9). The cells 
started retracting from their normal morphology giving rise to blank spaces in 
a uniformly spread cell monolayer. With increasing concentration and time 
they tended to become round detaching from the culture surface and coming 
into the medium. 
3.3.3.4. Cell viability 
The cell viability in the Comet assay exceeded 90% for all experimental 
groups (data not shown) before and after the treatment as assessed by 
Trypan blue dye exclusion assay. 
3.3.3.5. Genotoxic potential of ZnO nanoparticles 
A significant induction (p<0.05) in DNA damage was observed in cells 
exposed to ZnO nanoparticles for 6h at 8 and 14µg/ml concentrations 
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compared to control as evident by the Comet assay parameters i.e. Olive tail 
moment (arbitrary unit) and tail DNA (%) (Table 3.1). 
3.4. Discussion 
The human epidermal cells may be the first portal of entry for nanoparticles 
through consumer products and to some extent the environment. Moreover, 
any perturbation in the integrity of skin barrier may provide easy access to 
these nanoparticles into the skin. This necessitated the study to understand 
the biological consequences of interactions of ZnO nanoparticles with 
human skin cells. The present study demonstrates that ZnO nanoparticles 
are internalized in the human epidermal cells and elicit a cytotoxic response. 
We have also observed DNA damaging effects of ZnO nanoparticles on 
human epidermal cells for which lipid peroxidation and oxidative stress may 
be attributed as one of the probable reason. 
The characterization of ZnO nanoparticles was done by DLS and the mean 
hydrodynamic diameter was in the range of 245-273 nm. However, the size 
reported by its commercial supplier (Sigma–Aldrich, USA) using Brunauer–
Emmett–Teller (BET) method was 50-70nm, while that assessed by 
transmission electron microscopy (TEM) was 30nm. This difference in sizes 
is due to the fact that the methods employed (e.g. BET, TEM and DLS) are 
based on difference principles. The size obtained from DLS was more than 
the size measured by TEM (30 nm) or BET (50–70 nm). This can be 
attributed to the facts that (1) DLS measures Brownian motion and 
subsequent size distribution of an ensemble collection of particles in solution 
and gives mean hydrodynamic diameter which is usually larger than BET or 
TEM diameter as it includes a few solvent layers (Hradil et al., 2007); (2) 
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during DLS measurement there is a tendency of particles to aggregate in 
aqueous state thereby giving the size of clustered particles rather than 
individual particles; (3) it reports an intensity weighted average 
hydrodynamic diameter of a collection of particles so any polydispersity of 
the sample will skew the average diameter towards larger particle sizes. 
The internalization of ZnO nanoparticles was observed in primary human 
epidermal keratinocytes as revealed by the back scattered electron (BSE) 
imaging and transmission electron microscopy after 6h exposure at 14 
µg/ml. Analyzing sections of biological samples by back scattered electron 
imaging using a scanning electron microscope (SEM) enables brightly 
shining nanoparticles to be observed against the cellular dark background 
(Bastian et al. 2009). The nanoparticle agglomerates with strong BSE 
signals were visible in the cells when viewed by the BSE-SEM. In addition, 
the transmission electron microscopy also confirmed that ZnO nanoparticles 
were internalized in the cells. Although, the mechanism of ZnO nanoparticles 
uptake in keratinocytes remains to be elucidated, endocytosis has been 
suggested as the main mode of nanoparticle uptake by several authors. Xia 
et al. (2008) showed the uptake of ZnO nanoparticles in human lung 
epithelial cells (BEAS-2B) cells by endocytosis involving caveolae. This was 
also observed in A431 cells in our study where the ZnO nanoparticles were 
found to be present in the vesicles inside the cells. 
While evaluating the cytotoxic potential of ZnO nanoparticles in A431 cells, 
more than one assay of cytotoxicity was used to get more reliability. The 
cytotoxicity assays revealed a time and concentration dependent cytotoxicity 
in A431 cells on exposure to ZnO nanoparticles.  
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ZnO nanoparticles exposure in primary human epidermal cells also exhibited 
a time (6 -24 h) as well as concentration (8-20 µg/ml) dependent inhibition of 
mitochondrial activity.  A previous investigation revealed the cytotoxic nature 
of ZnO nanoparticles on human mesothelioma MSTO-211H and rodent 3T3 
fibroblast cells at concentrations of 3.75, 7.5 and 15µg/ml after 3-day 
exposure (Brunner et al. 2006). The cytotoxic doses of ZnO nanoparticles in 
this study were found to be in a very narrow range viz 8µg/ml to 20µg/ml. 
This is supported by a similar observation made previously for ZnO 
nanoparticles although in human lung carcinoma cells (A549; (Lin et al. 
2009b). Some earlier investigations have also observed the cytotoxic nature 
of these nanoparticles using diverse end- points in different mammalian cell 
types (Gojova et al. 2007; Jeng and Swanson 2006; Lai et al. 2008; Reddy 
et al. 2007; Sayes et al. 2007). The changes in cell morphology on exposure 
to ZnO nanoparticles also corroborated our cytotoxicity results (Figure 5). 
These morphological changes could be attributed to the cytotoxic potential of 
the ZnO nanoparticles evident by a decrease in the mitochondrial activity. 
The DNA damaging potential of the ZnO nanoparticles was assessed by the 
Comet assay which detects single as well as double strand breaks and alkali 
labile sites. Our results demonstrate that ZnO nanoparticles cause 
statistically significant DNA damage in A431 cells at concentrations of 5 and 
0.8µg/ml after an exposure period of 6h. A significant DNA damage was also 
observed at 14 µg/ml in primary human epidermal keratinocytes after 6 h 
exposure. Dufour et al. (2006) have shown a concentration related increase 
in chromosome aberrations after exposure to ZnO nanoparticles (<100 nm) 
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in CHO cells (Chinese hamster ovary), although at a very high concentration 
(≥105µg/ml).  
The production of free radicals is one of the primary mechanisms of 
nanoparticles toxicity (Nel et al. 2006). It may result in oxidative stress, 
inflammation and consequent damage to proteins, membranes and DNA 
(Donaldson and Stone, 2003). Therefore, the levels of GSH and the other 
antioxidant marker enzyme levels were assessed in the A431 cells. A 
significant depletion in the GSH, SOD and catalase levels were observed at 
0.8 and 0.08µg/ml on 24h exposure. This indicates a condition of oxidative 
stress in cells which may arise due to imbalance in the ROS formation and 
antioxidant defence system of cells. An increase in the lipid peroxidation 
which represents another marker of oxidative stress was also observed. This 
increase in lipid peroxidation may lead to membrane damage indicated by 
enhanced LDH release on ZnO nanoparticles exposure. As there is a well 
documented link between nanoparticles and oxidative stress, one of the 
possible modes that can be suggested for ZnO nanoparticles induced DNA 
damage and cell death is oxidative stress (Figure 3.10) (Xia et al. 2006). 
These results stress upon the need for a thorough safety/ toxicity 
assessment of new engineered nanoparticles that are used in consumer 
products. 
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Figure 3.1. Characterization of ZnO NPs (A-B) Hydrodynamic diameter and 
zeta potential in DMEM medium (C-D) Hydrodynamic diameter and zeta 
potential in KGM-2 medium (E) TEM microphotograph of ZnO NPs. 
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Figure 3.2. TEM microphotographs of human epidermal cells (A431)  (A) 
Control cells (B-C) Cells treated with ZnO NPs depicting intracellular 
localization of ZnO NPs (black arrow). 
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Figure 3.3. Cytotoxic effect of ZnO NPs in human epidermal cells (A431) as 
assessed by (a) MTT assay; (b) Neutral red uptake assay; (c) Lactate 
dehydrogenase release assay. Data are expressed as the percentage 
viability of cells exposed to ZnO NPs relative to control cells and are mean ± 
S.E.M. of triplicates.*p < 0.05, compared to control. 
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Figure 3.4. Morphology of human epidermal cells (A431) (A) normal, and 
ZnO NP treated (B) 8µg/ml for 6h, (C) 8µg/ml for 24h, (D) 8µg/ml for 48h.  
Magnification X100. 
 
Table 3.1. DNA damage by ZnO NPs after 6h exposure to human epidermal 
cells (A431) as evident by the comet parameters. 
 
Concentration Olive Tail Moment (OTM; arbitrary Units) % Tail DNA 
Control 
1mM EMS 
ZnO NPs (0.001μg/ml) 
ZnO NPs (0.008μg/ml) 
ZnO NPs (0.08μg/ml) 
ZnO NPs (0.8µg/ml) 
ZnO NPs (5µg/ml) 
1.37 ± 0.12 
20.83 ± 0.53** 
1.43 ± 0.17 
1.5 ± 0.1 
1.83 ± 0.18 
2.13 ± 0.12* 
2.33 ± 0.32* 
8 ± 0.71 
53.3 ± 1.2** 
9 ± 0.69 
9.2 ± 0.23 
11 ± 0.91 
10.6 ± 0.76* 
13 ± 1.50* 
 Values represent mean ± S.E.M of three experiments. 
 aEMS- ethyl methanesulfonate – positive control. 
 * p < 0.05; ** p < 0.01; *** p < 0.001 when compared to control 
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Figure 3.5. Effect of ZnO NPs on the oxidative stress markers in human 
epidermal cells (A431) (A) lipid peroxidation, (B) glutathione content, (C) 
catalase activity and (D) superoxide dismutase activity. Data represent 
mean± S.E.M. of three experiments. *p < 0.05, compared to control. 
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Figure 3.6. Scanning electron microscopy (back scattered electron imaging) 
microphotographs of primary human epidermal keratinocytes. (A) Control 
cells (B) Cells treated with ZnO NPs (14 µg/ml) for 6 h showing ZnO NP 
agglomerates (white arrow) inside cells. 
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Figure 3.7. Transmission electron microscopy microphotographs of primary 
human epidermal keratinocytes.  (A) Control cells (B) Cells treated with ZnO 
NPs (14µg/ml) for 6h depicting intracellular localization ZnO NPs (black 
arrow) (C) High power view shows localization of these nanoparticles in the 
filopodia. 
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Figure 3.8. Concentration and time dependent cytotoxicity of ZnO NPs in 
primary human epidermal keratinocytes. Data are expressed as the 
percentage viability of cells exposed to ZnO NPs relative to control cells and 
are mean ± S.E.M. of triplicates.*p < 0.05, compared to control. 
 
 
 
 
 
 
 
 
Figure 3.9. Morphology of primary human epidermal keratinocytes (A) 
Control cells and (B) Cells treated with  ZnO NPs (20µg/ml) for 6 h. 
Magnification X100.  
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Table 3.2.  DNA damage by ZnO NPs after 6 h exposure to primary human 
epidermal keratinocytes as evident by the comet parameters 
 
Concentration Olive Tail Moment 
(OTM; arbitrary Units) 
% Tail DNA 
Control 
H2O2† 
ZnO NPs (4μg/ml) 
ZnO NPs (8μg/ml) 
ZnO NPs (14μg/ml) 
0.77±0.08 
10.85±1.58*** 
0.92±0.02 
2.84±0.64* 
5.32±0.79** 
5.80±0.66 
31.19±2.09*** 
6.42±0.19 
14.62±2.44** 
19.90±1.79*** 
 Values represent mean ± S.E.M of three experiments. 
 †H2O2 ,Hydrogen peroxide-positive control (25µM for 15min). 
 * p < 0.05; ** p < 0.01; *** p < 0.001 when compared to control. 
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Figure 3.10. A representation of results from this study depicting the ZnO 
NPs induced cellular toxicity. 
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Mechanism of toxicity of ZnO nanoparticles 
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4.1. Introduction 
The field of nanotechnology is rapidly expanding with continuous 
development of nanomaterials based consumer products and industrial 
applications.  Nano forms of carbon based materials, metals, metal oxides 
and biopolymers are being used in several industries including diagnosis, 
drug delivery, cosmetics, sunscreens, food, paints, electronics, sports, 
imaging etc. Zinc oxide nanoparticles are one of the most abundantly used 
nanomaterials in cosmetics and sunscreens as they efficiently absorb UV 
light and also do not scatter visible light. This makes them transparent and 
more aesthetically acceptable compared to their bulk counterpart (Schilling 
et al. 2010). ZnO nanoparticles are being used in food industry as additives 
and in packaging due to their antimicrobial properties (Gerloff et al. 2009; Jin 
et al. 2009). They are also being explored for their potential use as 
fungicides in agriculture (Chen et al. 2005), antimicrobial agents in fabrics 
(Yadav et al. 2006) and as anticancer drugs and imaging in biomedical 
applications (John et al. 2010; Rasmussen et al. 2010). 
The increased production and use of ZnO nanoparticles enhances the 
probability of their exposure in occupational and environmental settings. This 
has raised concerns in the public and scientific community regarding their 
unanticipated and adverse health effects. Toxicity of ZnO nanoparticles has 
been evaluated in different biological systems, such as, bacteria (Miller et al. 
2003; Sinha et al. 2010), mammalian cells (Jeng and Swanson 2006; Wang 
et al. 2010a) and in vivo models (Wang et al. 2008a). In mammalian cells, 
the toxic effects of ZnO nanoparticles such as membrane injury, 
inflammatory response, DNA damage and apoptosis have been 
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demonstrated (Gojova et al. 2007; Jeng and Swanson 2006; Osman et al. 
2010; Yang et al. 2009a). In some studies, the toxicity of ZnO NPs has been 
ascribed to Zn2+ ions release (Franklin et al. 2007; George et al. 2009). 
However, studies have also shown that the toxicity of ZnO nanoparticles is 
due to their particulate nature which may give rise to reactive oxygen 
species (ROS) (Moos et al. 2010; Yang et al. 2009a). ROS generation is 
linked to DNA damage and cellular apoptosis (Cadet et al. 2010; Neuzil et al. 
2006) and is also known to activate the mitogen activated protein kinase 
(MAPK) pathways which are important mediators of signal transduction and 
play a key role in regulating many cellular processes (Navarro et al. 2006). 
Despite the existing studies on ZnO nanoparticle toxicity, the underlying 
molecular mechanism leading to toxicity remains largely unclear. Moreover, 
none of the studies, so far, have explored the adverse effects of ZnO 
nanoparticles in human liver which is the primary organ of metabolism. 
Given that humans are being directly exposed to ZnO nanoparticles, it 
seems logical that liver might act as a major target organ for ZnO 
nanoparticles after they have gained entry into the body through any of the 
possible routes. Therefore, the aim of the present study was to assess the 
cytotoxic and genotoxic potential of ZnO nanoparticles in human liver cells 
(HepG2) and to understand the mechanism involved.  
Cell lines of different origins have widely been used as a model for general 
toxicity studies because they are well characterized and more homogenous 
than primary cultures. They have been used to predict potential toxic effects 
as well as the mechanism of new toxicants on human body. Even the 
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regulatory authorities like OECD approve the use of cell lines in toxicity 
testing (OECD-473 1997).  
The HepG2 cell line is a well established in vitro toxicity model being used 
for toxicological assessment of a variety of compounds and xenobiotics 
(Chavan et al. 2011 ; Rouas et al. 2010; Slamenova et al. 2010; Wu et al. 
2010; Zhang et al. 2011). Dehn et al (2004) have shown that the HepG2 cell 
line is a useful in vitro model for cadmium toxicity studies and mimic in vitro 
and in vivo responses of mammalian systems. HepG2 cells display robust 
morphological and functional differentiation and have biosynthetic 
capabilities similar to those of normal hepatocytes. They produce most of the 
plasma proteins, retains cell surface receptors, can induce metallothionein in 
response to metals, can synthesize, assemble and secrete both very low 
and high density lipoproteins. HepG2 cells have been shown to retain P450-
dependent monooxygenase enzymes. They also have the ability to carry out 
normal biotransformation reactions essential to detoxification process. All 
these features have made this cell line a potentially useful model in 
investigating toxicity mechanisms (Chaudhary et al. 2010; Mantzaris et al. 
2011; Munro et al. 2008; Zhou et al. 2010); gene delivery studies (Le et al. 
2010), mitochondrial toxicity (Jasionek et al. 2010).  
Several recent studies involving toxicity assessment of engineered 
nanomaterials have used HepG2 as a model cell line (Jan et al. 2008; 
Kawata et al. 2009; Leonov et al. 2008; Liu et al. 2010; Nemmar et al. 2011; 
Romero et al. 2010; Thakor et al. 2011). Therefore in the present study it 
was found prudent to take HepG2 cells to understand the mechanism of 
toxicity of ZnO nanoparticles. 
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To achieve the aim of present study, a systematic study (Figure 4.1) which 
involved the assessment of cytotoxicity, ROS generation, lipid peroxidation, 
oxidative DNA damage and apoptosis was undertaken. Levels of key 
signalling and apoptotic proteins along with the involvement of MAPK 
signalling pathways were analyzed. We also investigated if the toxicity is 
being mediated by the Zn2+ ions liberated from nanoparticles. 
 
 
Figure 4.1. Schematic diagram of the study design. 
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4.2. Material and methods 
4.2.1. Dynamic light scattering 
ZnO NPs were suspended in complete minimal essential medium (CMEM; 
MEM supplemented with 10% FBS) at a concentration of 80 µg/ml and 
characterized by dynamic light scattering as described in Chapter 2 (2.2). 
4.2.2. Cell culture and exposure to nanoparticles 
The human hepatocarcinoma cell line (HepG2; procured from the National 
Centre for Cell Sciences, Pune, India) was cultured in CMEM containing 10 
ml/L of antibiotic and antimycotic solution at 37oC under a humidified 
atmosphere of 5%CO2/ 95% air.  
HepG2 cells were plated at a density of 105 cells/ml in a 96 well plate and 12 
well plate for the cytotoxicity assays (MTT, neutral red uptake and lactate 
dehydrogenase) and other parameters (Comet assay, apoptosis, 
mitochondrial membrane potential) respectively and allowed to attach for 
24h before the addition of NPs suspension. A stock suspension of ZnO NPs 
(80µg/ml) was prepared as described before and diluted to different 
concentrations (0.8, 2, 8, 14 to 20 µg/ml). Cells were then exposed to the 
above concentrations for varied lengths of time as per the experimental 
design.  
To investigate the role of oxidative stress in ZnO nanoparticles elicited toxic 
responses, cells co-treated with ZnO nanoparticles and 1mM NAC were also 
included in the MTT assay, Comet assay and apoptosis experiment. 
Similarly, for analyzing the role of different signalling pathways the cells were 
pre-treated with SB203580 (20µM) and SP600125 (20µM) for 2 h followed 
by simultaneous treatment of ZnO nanoparticles with the respective inhibitor. 
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After 24h exposure, the cells were checked for cell viability by the MTT 
assay. 
4.2.3. Cellular uptake of nanoparticles 
The cellular uptake of nanoparticles was analysed by flow cytometry (Suzuki 
et al. 2007) as described in Chapter 2 (2.3.1). 
4.2.4. Cytotoxicity assays 
4.2.4.1. MTT assay 
The cells were exposed to different concentrations of ZnO nanoparticles 
(0.8, 2, 8, 14 and 20 µg/ml) for 6, 12 and 24h. The mitochondrial activity was 
assessed using the MTT assay according to the method of Mosmann 
(Mosmann 1983) as described in Chapter 2 (2.4.1.) 
4.2.4.2. Neutral red uptake assay 
The neutral red uptake assay was done according to the method of 
Borenfreund and Puerner (1985) after exposing the cells to ZnO 
nanoparticles (0.8, 2, 8, 14 and 20 µg/ml) for 6, 12 and 24h. The method for 
neutral red uptake assay has been described in detail in the Chapter 2 
(2.4.2.). 
4.2.4.3. Lactate dehydrogenase release assay 
The cells were exposed to different concentrations of ZnO nanoparticles 
(0.8, 2, 8, 14 and 20 µg/ml) for 6, 12 and 24h. LDH activity in extracellular 
medium due to membrane damage was assessed by Tox-7 in vitro 
toxicology assay kit (Sigma–Aldrich Inc., St. Louis, MO, USA) using 
manufacturer’s protocol as described in Chapter 2 (2.4.3.). 
4.2.5. Measurement of intracellular reactive oxygen species (ROS) 
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The level of intracellular ROS generation was estimated by the method of 
(Wan et al. 1993) using 2,7-dichlorofluorescein diacetate (DCFDA; Sigma, St 
Louis, MO, USA) dye. Cells (1X104cells/well) were seeded in a 96-well black 
bottom plate. After 24h, the cells were exposed to ZnO NPs (8, 14, 20µg/ml) 
for 6h and the intracellular generation of ROS was measured as described in 
the Chapter 2 (2.5.1.). 
4.2.6. Lipid peroxidation 
The cells were cultured in 75-cm2 culture flask and exposed to ZnO 
nanoparticles (8, 14 and 20 µg/ml) for 24h. Subsequently, the levels of lipid 
peroxides were estimated by Cayman’s Chemicals Kit (USA) according to 
manufacturer’s protocol as described in Chapter 2 (2.5.2). 
4.2.7. Genotoxicity assessment 
4.2.7.1. Single cell gel electrophoresis/Comet assay 
The cells were exposed to ZnO nanoparticles (8, 14 and 20 µg/ml) for 6h 
and the DNA damage was assessed by the standard Comet assay which 
has been described in Chapter 2 (2.7.1.) 
4.2.7.2. Fpg-modified Comet assay 
The cells were exposed to ZnO nanoparticles (8, 14 and 20 µg/ml) for 6h 
and the oxidative DNA damage was assessed by the Fpg-mdified Comet 
which has been described in Chapter 2 (2.7.2.) 
4.2.8. Annexin V-FITC/PI staining 
Annexin V-FITC/PI staining was carried out by Annexin V-FITC apoptosis 
detection kit (Sigma, St Louis, MO, USA) as per the manufacturer’s protocol 
described in Chapter 2 (2.8.1).  
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4.2.9. Hoechst staining 
Apoptotic nuclear morphology was assessed using Hoechst 33342 (Sigma, 
St Louis, MO, USA) as described in Chapter 2 (2.8.2). 
4.2.10. Mitochondrial membrane potential 
Mitochondrial membrane potential (MMP) was detected with fluorescent 
probe 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine 
iodide (JC-1; Molecular probes, USA). Cells exposed to ZnO NPs were 
harvested by trypsinization and processed for MMP analyses as described in 
Chapter 2 (2.9). 
4.2.11. Western blot analysis 
Levels of key signalling and apoptotic proteins along with the involvement of 
MAPK signalling pathways were analyzed in cells exposed to ZnO 
nanoparticles using western blotting. The methodology for western blot 
analysis has been described before in Chapter 2 (2.10). 
4.2.12. Effect of dissolution on ZnO NPs induced cytotoxicity 
Zinc ions released from ZnO NPs were evaluated for their cytotoxicity. Cell 
culture medium containing ZnO NPs at a concentration of 20µg/ml was 
incubated at 37oC for 6, 12 and 24h. The NPs suspension was then 
centrifuged at 20,000 g (4oC) for 30 min to remove the NPs and the resulting 
supernatant was collected. Cell culture medium without nanoparticles, 
subjected to the same conditions was used as the blank control. The cells 
were incubated with the supernatant for 6, 12 and 24h and the cell viability 
was assessed by the MTT assay as described earlier.  
The Zn content in the supernatant was measured by an atomic absorption 
spectrophotometer (ZEEnit 700 P, Analytikjena, Germany). Before analysis, 
122 
 
the atomic absorption spectrophotometer (AAS) was calibrated every time 
by running at least three standard concentrations (0.25, 0.5 and 1 mg/L) of 
zinc. 
The cells were then treated with ZnCl2, equimolar in amount to the Zn 
content, found in the supernatant to evaluate the contribution of Zn2+ towards 
ZnO NP toxicity. The cytotoxicity was assessed after 6, 12 and 24h 
exposure by the MTT assay. 
4.2.13. Statistical analyses 
Results were expressed as the mean ± S.E.M. and data were analyzed by 
means of one way analysis of variance (ANOVA) with the Dunnett post hoc 
test to determine significance relative to the unexposed control using SPSS 
v. 16.0 software (SPSS Inc., Chicago, IL, USA). In all cases, p < 0.05 was 
considered significant. 
4.3. Results 
4.3.1. Dynamic light scattering 
The mean hydrodynamic diameter and zeta potential of the nanoparticle 
suspension in CMEM as determined by DLS measurement was 267nm and 
−12mV respectively (Figure 4.2A-B). 
4.3.2. Cellular uptake of ZnO nanoparticles 
The internalization of ZnO nanoparticles in human liver cells (HepG2) was 
assessed using flow cytometry. We observed a significant (p<0.05) increase 
in the SSC-A Mean of cells treated with ZnO nanoparticles (14 and 20µg/ml) 
for 3h as compared to the control cells (Figure 4.3). 
 
 
123 
 
4.3.3. Cytotoxicity of ZnO nanoparticles 
The cytotoxicity of ZnO nanoparticles in HepG2 cells was evaluated by the 
MTT, NRU and LDH assays. HepG2 cells were exposed to ZnO 
nanoparticles (0.8 to 20µg/ml) for 6, 12 and 24h. The MTT and NRU results 
demonstrated a concentration and time dependent cytotoxicity after 
exposure to nanoparticles (Figure 4.4A). The percentage mitochondrial 
activity (relative to control) observed after 12 h exposure at concentrations 
14 and 20µg/ml was 80 and 74% respectively with a further decrease to 53% 
and 43% after 24 h exposure.  
The results of the NRU assay showed a similar concentration and time 
dependent response with a loss in cell viability at 14 and 20µg/ml on 12 and 
24 h exposure (Figure 4.4B).  
A significant (p < 0.05) LDH leakage was observed at 14µg/ml and 20µg/ml 
after 24h and 12h exposure respectively (Figure 4.4C).  
4.3.4. Measurement of intracellular ROS 
A significant (p<0.05) qualitative and quantitative dose dependent increase 
in % ROS generation was observed in the form of fluorescence on treatment 
with ZnO nanoparticles for 6h at 14 and 20 µg/ml (Table 4.1, Figure 4.5).  
4.3.5. Effect of ZnO nanoparticles on lipid peroxidation 
Lipid peroxidation was examined by measuring hydroperoxide concentration. 
A statistically significant (p< 0.05) increase in hydroperoxide formation was 
observed only at the higher concentration (20 µg/ml; 20µM) after 6h 
exposure to ZnO nanoparticles (Table 4.1). 
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4.3.6. DNA damage 
The cell viability in the Comet assay exceeded 90% for all experimental 
groups before and after the treatment as assessed by the Trypan blue dye 
exclusion assay (data not shown). 
A significant induction (p < 0.05) in DNA damage was observed in cells 
exposed to ZnO nanoparticles for 6h at 14 and 20µg/ml concentrations 
compared to control cells in standard alkaline Comet assay as evident by the 
Comet assay parameters i.e. Olive tail moment (arbitrary unit) and % tail 
DNA (Table 4.2; Figure 4.7). Moreover, in Fpg modified Comet assay, the 
OTM values of cells treated with 14 and 20 µg/ml ZnO nanoparticles were 
significantly higher than the respective OTM values observed in standard 
alkaline Comet assay suggesting the oxidative DNA damage. Additionally, 
cells exposed to the same concentrations of ZnO nanoparticles revealed a 
significant (p<0.05) increase in Fpg sensitive sites compared to control cells 
incubated with Fpg enzyme (Table 4.2). To further confirm the involvement 
of oxidative stress, the level of Fpg sensitive sites were evaluated in the cells 
exposed to 20µg/ml ZnO nanoparticles in the presence of NAC. The results 
revealed a protective effect of NAC on oxidative DNA damage as evident by 
a reduction in Fpg sensitive sites (Figure 4.6). The protective effect of NAC 
increased as its concentration increased from 0.75mM to 1mM exhibiting a 
26% and 53% reduction respectively in Fpg sensitive sites. 
4.3.7. Apoptosis 
Flow cytometry analysis was conducted using AnnexinV-FITC/PI staining to 
investigate the mode of cell death induced by ZnO nanoparticles. HepG2 
cells were treated with 14 and 20 µg/ml ZnO nanoparticles for 12h. The 
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control cells were not stained with AnnexinV-FITC and propidium iodide. 
However, the cells treated with 14 and 20 µg/ml ZnO nanoparticles for 12h 
showed 8.1 and 12.8 % apoptotic cells respectively (Figure 4.8A-C). While at 
14µg/ml, more cells were in early apoptotic phase (5.93% vs 0.57% in 
control) then in late phase (2.17% vs 0.27% in control.); at 20µg/ml a 
noticeable cluster of cells appear in late apoptotic quadrant (7.57%) 
compared to early apoptotic populations (5.23%). This is due to a high 
intensity of cell death at the high concentration leading to shifting of cells 
from early apoptotic phase to late apoptotic phase. 
The apoptosis was further confirmed by employing Hoechst 33342 staining. 
Stained control and ZnO nanoparticles treated cells were examined for 
nuclear morphology. The control cells had round and homogenously stained 
nuclei but cells treated with ZnO nanoparticles (14 and 20 µg/ml) for 12h 
showed marked DNA condensation and apoptotic bodies, characteristic of 
apoptosis (Figure 4.9).  
4.3.8. Mitochondrial membrane potential (∆ψm) analysis 
 The cells treated with ZnO nanoparticles for 12h showed a marked 
decrease in ∆ψm evident by a shift in JC-1 fluorescence from red to green 
(Figure 4.10). This decrease in ∆ψm was concentration dependent with 15.2 
and 18.8 % depolarized cells at 14 and 20µg/ml respectively as compared to 
control cells (9.7%). When examined by fluorescent microscopy, the control 
cells showed an intense red fluorescence and weak green fluorescence. 
However, the ZnO nanoparticles treated cells exhibited a bright green 
fluorescence with a marked decrease in red fluorescence indicating a loss of 
MMP (Figure 4.11). 
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4.3.9. Analysis of key apoptotic and signalling proteins 
The levels of key apoptotic and signalling proteins were examined in cells 
exposed to ZnO nanoparticles for 9h by western blotting (Figure 4.12A-C). 
The cells showed modulation of Bax and Bcl2 protein expression levels with 
an increase in Bax levels and a corresponding decrease in Bcl2. A 
significant decrease in the procaspase 9 levels (0.5 fold) and an appearance 
of a cleavage product at 37kD was observed. Detection of P53 and 
phosphorylated P53Ser15 levels was also carried out and a 2.4 fold increase 
in the levels of phospho-P53Ser15 was observed without any significant 
change in the levels of P53. No changes in NF-kβ levels were observed on 
exposure to ZnO nanoparticles. 
4.3.10. Effect of ZnO nanoparticles on MAPK phosphorylation  
We examined the effect of ZnO nanoparticles treatment on the 
phosphorylation state of the extracellular signal-regulating kinase (ERK1/2), 
stress activated protein kinase (SAPK)/ Jun-N-terminal kinase (JNK), and 
P38 kinase in HepG2 cells by western blotting (Figure 4.13). A 1.8-2.2 fold 
increase in the phosphorylated JNK was observed at 20 and 14 µg/ml after 
9h but no change was found in JNK proteins. Similarly, there was 1.8-2.4 
fold upregulation of phosphorylated P38 expression without any modulation 
of P38 expression. No changes in phospho-ERK and ERK levels were 
observed on exposure to ZnO nanoparticles. Interestingly, P38 and JNK 
phosphorylation was completely abrogated in the presence of NAC (Figure 
4.14). 
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4.3.11. Effect of NAC, SP600125, and SB203580 on ZnO nanoparticle 
induced toxicity 
To determine the role of ROS and other signalling pathways in ZnO 
nanoparticles induced cell death, HepG2 cells were treated with ZnO 
nanoparticles (20µg/ml) in the presence of NAC (antioxidant), SP600125 
(JNK inhibitor) and SB203580 (P38 inhibitor). The effect on cell viability was 
measured by the MTT assay (Figure 4.15).  The presence of NAC 
completely abolished the cytotoxic effect of ZnO nanoparticles and showed 
cell viability similar to control cells even after 24h of exposure. However, 
addition of SP600125 (JNK inhibitor) and SB203580 (P38 inhibitor) did not 
provide any protection from ZnO nanoparticles induced cell death in HepG2 
cells.  
The presence of NAC significantly (p<0.05) decreased the number of 
depolarized cells (Figure 4.16A). AnnexinV-FITC/PI and Hoechst 33342 
staining indicated that NAC was able to protect cells from ZnO nanoparticle 
induced apoptosis (data not shown). Bax/Bcl2 modulation and P53Ser15 
phosphorylation was also noticeably inhibited by NAC addition (Figure 
4.16B). 
4.3.12. Analysis of released Zn2+ and its cytotoxicity  
The cells exposed to ZnO nanoparticle supernatant for 6, 12 and 24h 
showed same cell viability as that of control cells in MTT assay (Figure 
4.17A).  
The AAS analysis of the supernatant revealed a Zn2+ of 1.2ppm (18.46µM) 
for all time periods (Figure 4.17B).  The cells were further treated with a 
soluble Zn salt- ZnCl2 at equivalent Zn mass dose (18µM) for 6, 12 and 24h 
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and the cytotoxicity was assessed by the MTT assay. The assay revealed no 
decrease in cell viability on 6, 12 and 24h exposure to ZnCl2 (Figure 4.17C). 
4.4. Discussion 
The present study explores the effects of ZnO nanoparticles on human liver 
cells and provides significant insight into the possible mechanism through 
which ZnO nanoparticles exert their toxic effects on these cells. Our results 
demonstrate the cytotoxic and genotoxic potential of ZnO nanoparticles in 
human liver cells. Oxidative stress and not dissolution was found to be the 
underlying mechanism behind ZnO nanoparticle induced DNA damage and 
cell death. Our data also revealed that the mode of cell death was apoptosis 
which was mediated by ROS triggered mitochondrial pathway as evidenced 
by decrease in MMP, modulation of Bax/Bcl2 ratio and cleavage of caspase-
9 (Figure 4.18). Finally, we also investigated the status and role of some 
major signalling molecule like MAPK and P53. Interestingly, JNK and P38 
activation was observed, however, with minimal effect on ZnO nanoparticle 
induced apoptosis. 
The interference of some nanomaterials with commonly used cytotoxicity 
test systems has been well documented in the literature (Monteiro-Riviere et 
al. 2009). Therefore, it has been suggested that the cytotoxicity of 
nanomaterials should be assessed with two or more independent test 
systems for validating the findings (Monteiro-Riviere et al. 2009). We 
evaluated the cytotoxicity of ZnO nanoparticles by three different assay 
systems viz. the MTT assay, NR uptake and LDH release assay to increase 
the reliability of the data.  The assays revealed a cytotoxic potential of ZnO 
nanoparticles at 14 and 20 µg/ml after 12 and 24h exposure in HepG2 cells. 
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The concentration dependence of ZnO nanoparticle toxicity showed a steep 
response. This steep dose response pattern of ZnO nanoparticle toxicity is in 
agreement with the studies of Wang et al. (2008) and Lin et al. (2009) 
carried out on Chinese hamster ovary (CHO) cells and human alveolar 
epithelial (A549) cells respectively.  
Oxidative stress is the most discussed paradigm for the toxicity of 
nanoparticles.  This has been attributed to their small size and hence large 
surface area which is generally thought to elicit ROS generation and 
oxidative stress (Xia et al. 2006). The ZnO nanoparticles in our study were 
also found to be capable of generating intracellular ROS when examined by 
the cell permeable dye DCFH-DA. This observation is consistent with the 
earlier studies of Yin et al (2010) and Yang et al (2009a) who observed 
similar effects on WIL2-NS human lymphoblastoid cells and primary mouse 
embryo fibroblast cells respectively. We also observed an increase in lipid 
peroxides in HepG2 cells on exposure to ZnO nanoparticles, which 
represents another marker of oxidative stress. Lipid peroxidation can further 
give rise to more free radicals and damage biomolecules like DNA, protein 
and lipids in conjunction with ROS. It also causes injury to the cell 
membrane as indicated by an increased LDH release. Different ways for 
ROS generation by engineered nanoparticles have been proposed (Song et 
al. 2009; Xia et al. 2006). The nanoparticles can lead to spontaneous ROS 
generation at their surface owing to their chemical and surface 
characteristics. They can also lead to the generation of free radicals after 
their interaction with cellular components e.g. mitochondrial damage. One 
more way of ROS production is the activation of NADPH-oxidase enzyme 
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which is responsible for O2- production in the membrane of phagocytic cells. 
In case of ZnO nanoparticles, the generation of ROS has been attributed to 
their semiconductor and nanolevel characteristic which leads to ROS 
generation even in the absence of light.  This has already been explained in 
detail by Rasmussen et al (2010) (Rasmussen et al. 2010). The quality of 
ZnO nanocrystal decreases with decreasing nanoparticle size and results in 
increased interstitial zinc ions and oxygen vacancies (Nel et al. 2006; 
Sharma et al. 2009). These crystal defects can lead to a large number of 
electron-hole pairs which can migrate to the nanoparticle surface and 
contribute to the ROS generation. The electron and holes can react with the 
oxygen and hydroxyl ions respectively present in the ZnO nanoparticles 
aqueous environments. This produces highly reactive free radical 
compounds including the superoxide anion radical (from electrons) and the 
hydroxyl radical (from holes) (Rasmussen et al. 2010). When in contact with 
the cellular environment, these radicals can oxidize and reduce 
macromolecules (DNA, lipids, proteins) resulting in significant oxidative 
damage to cell. 
Some nanoparticles owing to their small size are capable of reaching the 
nucleus  and might attack DNA (Chen and Mikecz 2005). They may also 
exhibit an indirect effect on DNA through their ability to generate reactive 
oxygen species. This DNA damage may either lead to carcinogenesis or cell 
death, thus disrupting normal cell functions. We observed the genotoxic 
potential of ZnO nanoparticles in HepG2 cells in the alkaline Comet assay 
which is capable of detecting single as well as double DNA strand breaks 
and alkali labile sites even at low levels of DNA damage (Collins 2004). Our 
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earlier studies have also revealed the DNA damaging potential of these 
nanoparticles in somatic cells (skin cells, lymphocytes) and germ cells 
(Gopalan et al. 2009).  As ROS is known to react with DNA molecules 
causing damage to both purine and pyrimidine bases as well as DNA 
backbone (Martinez et al. 2003), we investigated the link between oxidative 
stress and DNA damage in HepG2 cells via the Fpg modified Comet assay. 
The bacterial enzyme Fpg recognizes specifically the most common marker 
for DNA oxidation- 8-oxo-7, 8-dihydroguanine (8-oxoGua). In the present 
study, the levels of Fpg-sensitive sites (oxidised purines) increased as 
compared to the levels of direct single strand breaks as observed in 
standard Comet assay. Moreover, NAC was able to give protection against 
these ZnO nanoparticle induced DNA strand breaks and oxidative DNA 
damage. This confirms oxidative stress as the mediator of ZnO 
nanoparticles induced DNA damage. These results are in agreement with 
the findings of Karlsson et al (2008) who observed oxidative DNA lesions in 
cultured A549 cells after exposure to 20 μg/cm2 (40 μg/mL) and 40 μg/cm2 
(80 μg/mL) ZnO nanoparticles for 4h.  
The ZnO nanoparticle induced cell death observed in this study can occur by 
two distinct modes- apoptosis and necrosis which can be distinguished by 
morphological and biochemical features. While necrosis is usually induced 
by pathological and accidental damage to cells, apoptosis accounts for most 
of the physiological cell death and is a tightly regulated process controlled by 
a complex set of molecules (Elmore 2007). To know the mode of ZnO 
nanoparticles induced cell death, ZnO nanoparticles treated cells were 
incubated with AnnexinV-FITC/PI and analyzed by flow cytometry. 
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AnnexinV/PI staining of ZnO nanoparticle treated HepG2 cells resulted in an 
increase in AnnexinV+/PI- and AnnexinV+/PI+ cells compared to the control 
(AnnexinV-/PI-) indicating apoptosis as a possible mode of cell death. To 
further confirm that ZnO induced cell death represented apoptosis we 
examined the cells stained with Hoechst 33342 and found nuclear 
condensation and fragmentation which is another morphological hallmark of 
apoptosis.  
Apoptosis can be mediated by different routes, out of which one major 
pathway is mitochondrial pathway (also known as the intrinsic pathway) 
which is triggered by a wide range of stimuli. The intrinsic pathway is 
regulated by the proteins of the Bcl-2 family. The relative expression levels 
of the pro-apoptotic (Bax) and the anti-apoptotic proteins (Bcl-2) decides the 
fate of the cell towards programmed death. In order to examine the role of 
the Bcl-2 family in ZnO nanoparticle induced apoptosis, the effects of ZnO 
nanoparticles on Bax and Bcl-2 protein levels were analyzed by Western 
blotting and an increase in Bax levels with a corresponding decrease in Bcl-
2 levels was observed. Another key event in the intrinsic pathway is 
disruption of the mitochondrial trans-membrane potential. This leads to 
osmotic mitochondrial swelling with subsequent rupture of the outer 
mitochondrial membrane, resulting in the release of pro-apoptotic proteins 
(e.g cytochrome c, apoptosis inducing factor) from the mitochondrial inter-
membrane space into the cytoplasm. Cytochrome c induces the formation of 
apoptosome which binds to downstream caspases, such as procaspase-9, 
and processes them into proteolytically active forms. Active caspase-9 
further mediates activation of effector caspases resulting in apoptosis. We 
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analyzed this crucial step of mitochondrial membrane depolarization in ZnO 
nanoparticle treated cells and found a collapse of ∆Ψm following treatment 
with ZnO nanoparticles. We also observed the activation of caspase-9 as 
proved by a decrease in the pro-caspase level accompanied by an 
appearance of 37kD cleavage product. Our results clearly demonstrate the 
role of mitochondria mediated pathway (intrinsic pathway) in ZnO 
nanoparticle induced apoptosis. 
Investigating the effect of ZnO nanoparticles on MAPK and their importance 
in ZnO induced apoptosis was another important part of this study. MAPK is 
a common signalling pathway activated in response to various cellular 
stimuli such as oxidative stress (Chang and Karin 2001). The MAPK 
pathways consist of three main members, the extracellular signal-regulating 
kinase (ERK1/2), stress activated protein kinase (SAPK)/ Jun-N-terminal 
kinase (JNK), and the P38 pathways, which govern important cellular 
activities like proliferation, differentiation, stress responses etc. The JNK 
pathway has been identified as a direct activator of the mitochondrial death 
machinery providing a molecular linkage from oxidative stress to the 
mitochondrial apoptosis machinery. It is known to cause the release of 
cytochrome c and AIF by selective permeabilization of the outer 
mitochondrial membrane (Aoki et al. 2002). Anti-apoptotic Bcl-2 family 
proteins, namely Bcl-2 and BclxL were found to be phosphorylated by JNK 
suppressing their anti-apoptotic function (Maundrell et al. 1997). Therefore, 
we evaluated the link of MAPK with ROS production and apoptosis. We 
demonstrated that treatment of HepG2 cells with ZnO nanoparticles caused 
JNK and P38 activation, however, the status of ERK remained unaltered. In 
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addition, P38 and JNK activation was completely abolished in the presence 
of NAC suggesting that there is a ROS-dependent induction of JNK and p38 
by ZnO nanoparticles. These results point to the possibility that ROS - 
evoked JNK and P38 activation triggered the mitochondrial-dependent cell 
death pathway based on the well established role of these kinases in ROS 
mediated apoptosis (Aoki et al. 2002). Interestingly, Inhibition of JNK and P-
38 pathway by using their specific inhibitors (SP600125 and SB203580 
respectively) failed to protect cells from apoptosis. This shows that JNK and 
P38 kinases play no direct role in the apoptosis induced by ZnO 
nanoparticles. However, their activation by ZnO nanoparticle generated 
reactive oxygen species might be explained as an adaptive response to 
bypass the stress injury (El-Najjar et al. 2010). The importance of MAPK 
cascade in nanoparticles induced cellular responses has not been explored 
much despite their multifunctional role in cell signalling especially under 
various stress conditions (Chang and Karin 2001).  
It has been shown that tumor suppressor protein P53 is involved in cell cycle 
arrest, DNA repair and apoptosis in response to genotoxic and oxidative 
stress (Liu et al. 2008). P53 downregulates anti-apoptotic Bcl2 proteins and 
trans-activates puma, noxa and pro-apoptotic Bax to trigger the 
mitochondrial pathway of apoptosis (Pietenpol and Stewart 2002). Various 
stress stimuli leads to phosphorylation of P53 at different sites which 
stabilizes and activates it. DNA damage induces phosphorylation of P53 at 
ser15 (Shieh et al. 1997). We therefore investigated activation of P53; link 
between ROS and P53 activation; and whether it is required for ZnO 
nanoparticle induced apoptosis. We observed an enhanced phosphorylation 
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of P53 at ser15 in HepG2 cells on exposure to ZnO nanoparticles. This 
phosphorylation could be abrogated by NAC demonstrating an oxidative 
stress induced P53 activation. This activation may also be explained as a 
response to DNA damage which is caused by ZnO nanoparticles induced 
ROS. We also sought to investigate the status of NFκB in HepG2 cells 
exposed to ZnO nanoparticles and found no modulation in its expression. 
NFκB is an important transcription factor controlling many important 
functions such as immunity. inflammation, and apoptosis (Gilmore 1999). 
However, a better approach to moniter the activity of this transcription factor 
is to study its translocation to the nucleus as the increase in the NFκB 
expression in response to any external factor may be too minimal to be 
detected by Western blotting. 
To decipher the link between oxidative stress and ZnO nanoparticle induced 
toxicity in HepG2 cells, the cells treated with ZnO nanoparticles in the 
presence of NAC. NAC completely abolished ZnO nanoparticle induced 
apoptosis. It was also evaluated whether ROS targeted the mitochondria 
and thereby decreased the ∆Ψm in ZnO nanoparticle-treated HepG2 cells. 
We observed that a loss of MMP and increased Bax/Bcl-2 ratio induced by 
ZnO nanoparticle could also be inhibited in the presence of NAC. These 
results indicated that ROS caused the ∆Ψm loss, Bax/Bcl-2 modulation and 
caspases activation, which accounted for the ZnO nanoparticle induced 
HepG2 apoptosis. A direct link between ROS and apoptosis is possible as 
ROS production causes dimerisation of Bax in the cytosol. This changes 
conformation of Bax exposing its mitochondrial docking motif leading to 
translocation of Bax to mitochondria, channel formation and release of 
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cytochrome c (Neuzil et al. 2006). These results are supported by the 
findings of Heng et al. (2010) who demonstrated that initial exposure of 
human bronchial epithelial cells (BEAS-2B) to oxidative stress increased 
their sensitivity to the cytotoxic potential of ZnO nanoparticles. 
Some studies have raised doubt in ascribing the ZnO nanoparticles toxicity 
to ROS or nanoparticles per se and observed dissolution as the main cause 
(Franklin et al. 2007). Moreover, the phenomenon of dissolution is expected 
to become more prominent in case of nanoparticles due to its dependency 
on the surface area. The toxicity of resulting metal ions is well known and 
accepted. Brunner et al  (2006) observed that more soluble nanoparticles 
like ZnO and FeO showed greater cytotoxicity then insoluble nanoparticles 
such as CeO2 and TiO2 in human mesothelioma MSTO-211H and rodent 
3T3 fibroblast cells, however, any correlation with the  phenomenon of 
dissolution was not demonstrated experimentally. Therefore, we addressed 
the probability of released Zn2+ contribution towards toxicity in our study by 
two different ways. We incubated cell culture media containing nanoparticles 
at 37oC for 6, 12 and 24h while mimicking the cell exposure conditions. The 
supernatant from this media did not result in toxicity at any time period 
discarding any contribution of released Zn2+ towards toxicity. To further 
understand the dissolution process taking place in our experimental 
conditions, we measured the Zn content in supernatant by AAS. We found 
that the [Zn2+] reached a level of 1.2 ppm in 6h and remained constant for 12 
and 24h. Therefore, the maximum extent of dissolution that we got resulted 
in 6h itself and remained constant for next 24h showing that the liberation of 
Zn2+ from nanoparticles is independent of time, in given conditions. We also 
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attempted to answer the issue of dissolution by exposing cells to an 
appropriate reference material- ZnCl2 at the Zn mass dose (18uM) equimolar 
to Zn content in supernatant. No decrease in cell viability was observed at 6, 
12 and 24h and this corroborated our results that the impact of Zn2+ release 
on toxicity is insignificant. This finding suggests that although the 
nanoparticles release Zn2+ in the media but this amount is insufficient to 
cause toxicity. Therefore, the observed toxic responses on exposure to ZnO 
nanoparticles are due to the nanoparticles per se rather than the ions 
released from them. Our results are in agreement with those of Lin et al. 
(2009a) and Gojova et al. (2007) who demonstrated that there is no ionic 
toxicity on ZnO nanoparticles exposure, although it was done in different 
cellular systems and exposure conditions. 
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Figure 4.2. Characterization of ZnO NPs; (A) Hydrodynamic diameter; (B) 
Zeta potential. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Cellular uptake of ZnO NPs in HepG2 cells as assessed by the 
flow cytometry (A) Control (B-D) ZnO NPs exposed cells. 
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Figure 4.4. Cytotoxic effect of ZnO NPs in HepG2 cells as assessed by (A) 
MTT assay; (B) Neutral red uptake assay; (C) Lactate dehydrogenase 
release assay. Data are expressed as the percentage viability of cells 
exposed to ZnO NPs relative to control cells and are mean ± S.E.M. of 
triplicates.*p < 0.05, compared to control. 
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Table 4.1.  Effect of ZnO NPs on the ROS generation and lipid peroxidation 
in HepG2 cells after 6h exposure. 
 
Concentrations          ROS generation 
          (% of control) 
Hydroperoxide concentration
                      (nmol) 
    
Control 100 ± 7                                           1.5 ± 0.05 
ZnO NPs (8 µg/ml) 102 ± 5       1.4 ± 0.08  
ZnO NPs (14 µg/m 116 ± 8       1.8 ± 0.04  
ZnO NPs (20 µg/m  131 ± 5*         2.6 ± 0.03*  
Values represent mean ± S.E. of three experiments. 
* p < 0.05 when compared to control using one way ANOVA 
 
 
 
 
Figure 4.5. Photomicrographs showing generation of the intracellular 
reactive oxygen species using DCFDA dye in HepG2 cells (A) Control cells; 
(B) Cells exposed to ZnO NPs for 6h showing increase in fluorescence 
(Magnification X200). 
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Table 4.2. Induction of DNA strand breaks and oxidative DNA damage in 
human liver cells after 6h exposure to ZnO nanoparticles as evident by the 
Comet parameters.  
 
Concentrations OTM (arbitrary unit) Tail DNA (%) 
Fpg (-) Fpg (+) Fpg (-) Fpg (+) 
Control 0.87±0.14 1.21±0.15 5.75±0.88 7.19±0.46 
ZnO NPs (8 µg/ml) 1.00±0.08 1.32±0.19 6.80±0.38 8.62±0.79 
ZnO NPs (14 µg/m 1.68±0.19* 2.25±0.15* α 8.90±0.76* 11±0.62* 
ZnO NPs (20 µg/m 2.17±0.20* 4.09±0.05*α 11.15±0.11* 14.51±0.55* α 
Values represent mean ± S.E. of three experiments. 
* p < 0.05 when compared to control using one way ANOVA 
α p < 0.05 when compared to Fpg (-) at the same concentration using 
Student ‘t’ test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Effect of N-acetyl cysteine (NAC) on ZnO NP induced oxidative 
DNA damage in HepG2 cells; Data represents mean ± S.E.M. of three 
experiments.*p < 0.05 when compared to control using one way ANOVA in 
Fpg-modified Comet assay. αp < 0.05 using when compared to “(-) NAC” at 
the same concentration using the Student ‘t’ test.  
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Figure 4.7. HepG2 cells treated with ZnO NPs showing oxidative DNA 
damage (magnification X400) (A) Control cells in standard alkaline Comet 
assay; (B) Control cells in Fpg-modified Comet assay; (C) ZnO NPs 
(20µg/ml) treated HepG2 cell in standard Comet assay; (D) ZnO NPs 
(20µg/ml) treated HepG2 cell in Fpg-modified Comet assay. 
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Figure 4.8.  ZnO NPs induced apoptosis in HepG2 cells - (A) Control cells; 
(B) Cells treated with 14µg/ml ZnO NPs; (C) Cells treated with 20µg/ml ZnO 
NPs. Quadrants: Q1- necrotic cells; Q2- necrotic cells or late phase of 
apoptotic cells; Q3- unstained live cells, Q4- Early apoptotic cells. 
Representative dot plots of three independent experiments are presented. 
Data represent mean ± S.E.M. of three experiments. 
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Figure 4.9. Fluorescence images of cells stained with Hoechst 33342. ZnO 
NP treated cells show apoptotic cells with condensed or fragmented nuclei 
(indicated by arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10. ZnO NPs induced mitochondrial membrane potential (MMP) 
changes in HepG2 cells - (A) Control cells; (B) Cells exposed to 14µg/ml 
ZnO NPs; (C) Cells exposed to 20µg/ml ZnO NPs. 
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Figure 4.11. Fluorescence images of ZnO NP induced changes in MMP in 
HepG2 cells. The first (extreme left) column showing only green 
fluorescence (aggregated form of JC-1), the second (middle) column 
showing only red fluorescence (monomeric form of JC-1), the third (extreme 
right) column showing overlay (red-green fluorescence). 
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Figure 4.12. Western blot analysis of proteins involved in apoptosis: (A) 
Bax, Bcl2, NF-kβ expression levels, caspase-9 activation and p53Ser15 
phosphorylation. β-actin was used as internal control to normalize the data. 
(B-C) Relative quantification of protein expression levels. Data represent 
mean ± S.E.M. of three experiments.*p < 0.05, compared to control. 
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Figure 4.13. Western blot analysis of proteins involved in MAPK signalling in 
HepG2 cells - (A) Effect of ZnO NPs exposure. (B) Relative quantification of 
protein expression levels. Quantification was done using scion image 
software. Data represent mean ± S.E.M of three experiments.*p < 0.05, 
compared to control. 
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Figure 4.14. Effect of NAC on ZnO NP induced MAPK signalling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. Effect of MAPK inhibition and N-acetylcysteine on ZnO NPs 
induced cytotoxicity in HepG2 cells. Data represent mean±S.E.M. of three 
experiments.*p < 0.05, compared to cell treated with ZnO NPs only. 
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Figure 4.16. Effect of N-acetylcysteine on mitochondrial mediated apoptosis 
(A) Effect of N-acetylcysteine on ZnO NPs induced loss of MMP. Data 
represent mean ± S.E.M. of three experiments. *p<0.05 when compared to 
control. αp<0.05 using when compared to “without NAC” at the same 
concentration. (B) Effect of N-acetylcysteine on ZnO NPs induced Bax, Bcl2 
and p53 phosphorylation. β-actin was used as internal control to normalize 
the data. Blots shown are representative of three different experiments. 
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Figure 4.17. Effect of dissolution on ZnO NPs induced cytotoxicity (A) 
Assessment of cytotoxicity of Zn2+ released into the medium from ZnO NPs. 
(B) Assessment of Zn2+ released from ZnO NPs. (C) Assessment of 
cytotoxicity of released Zn2+ using ZnCl2 as the reference standard. The 
cytotoxicity was assessed by the MTT assay after 6, 12, and 24h exposure. 
Data represent mean ± S.E.M. of three experiments. 
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Figure 4.18. Possible mechanisms involved in ZnO NPs induced toxicity in 
human liver cells. 
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       CHAPTER – 5 
 
 
 
 
 
 
 
 
 
In vivo toxicity of ZnO nanoparticles in 
mice 
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5.1. Introduction 
The toxicity assessment of any novel entity in the in vivo systems is always 
desirable. This is due to the complex cell-cell, cell-matrix interactions, 
diversity of cell types, hormonal effects that are hard to mimic in the in vitro 
systems. In addition, studying long term chronic effects of the test compound 
is also not possible without in vivo experiments. The importance of the in 
vivo studies in the area of nanomaterial toxicology has already been 
highlighted (Fischer and Chan 2007).  
There are no existing guidelines and standard methodologies for risk 
assessment of nanomaterials. However, the “committees on toxicity (COT), 
mutagenicity (COM) and carcinogenicity (COC) of chemicals in food, 
consumer products and the environment, UK” have suggested extrapolating 
the in vitro nanotoxicity findings to in vivo experiments and confirm the 
results (COT;COM;COC 2005).The same committees (COT, COM and 
COC) have also advised to consider appropriate route of exposure in the in 
vivo experiments. In case of engineered nanoparticles, the exposure and 
uptake can occur through different routes. For ZnO nanoparticles, the oral 
exposure and uptake through the gastrointestinal route needs to be 
considered. This is keeping in view the fact that ZnO nanoparticles can be 
ingested directly when used in food, food packaging, drug delivery and 
cosmetics. Workers involved in ZnO nanoparticles synthesis can be exposed 
by unintentional hand-to-mouth transfer of nanomaterials. When discharged 
into the environment accidently, these nanoparticles may enter the human 
body through food chain. In addition, some of the nanoparticles can be 
swallowed into the gastrointestinal tract when they are expelled from the 
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mucociliary system of the lungs after inhalation exposure (Hussain et al. 
2001; Oberdorster et al. 2005). Nanoparticles could be then translocated 
from the lumen of the intestinal tract and blood into different organs like liver.  
Earlier studies have shown that nano forms of different particles are more 
toxic then their micro-counterparts after acute exposure via oral route (Chen 
et al. 2006; Meng et al. 2007; Wang et al. 2007). Biodistribution experiments 
have revealed liver, kidney and spleen as the target organs for engineered 
nanoparticles after uptake by gastrointestinal tract (Chen et al. 2006; Cui et 
al. 2011; Wang et al. 2007). For ZnO nanoparticles, only a few in vivo 
studies are available and most of them are focused on respiratory tract 
exposure (Sayes et al. 2007; Warheit et al. 2009). A previous study 
evaluated the acute oral toxicity of ZnO nanoparticles at a high dose range 
(1-5g/kg body weight) and found a decrease in liver, spleen and pancreas 
damage with the increase in nanoparticle dose (Wang et al. 2008a). They 
attributed this pattern to increased agglomeration at higher doses and 
suggested the need to study ZnO nanoparticle induced oral toxicity at low 
doses. Moreover, these studies revolve around the general toxicity 
parameters and have not considered the genotoxic potential of ZnO 
nanoparticles as well as investigating the mechanism of its toxicity.  
Therefore, the present study was undertaken to investigate the acute oral 
toxicity of ZnO nanoparticle including its genotoxicity and the mechanism of 
toxicity involved. In addition, we also sought to evaluate if the toxic 
responses and the mechanism of toxicity involved in vitro studies are also 
being observed in the in vivo scenario. For this we exposed mice to ZnO 
nanoparticles via the oral route according to the OECD guidelines (OECD-
156 
 
420 2001) and the distribution of nanoparticles in different tissues was 
investigated. The effects of nanoparticles on body/tissue weight and serum 
biochemical parameters were also examined. Additionally, we analyzed the 
genotoxic effects of these particles by in vivo comet assay and the organ 
damage by histopathology. To understand the mechanism of cell death, we 
measured the oxidative damage by lipid peroxidation and Fpg-modified 
Comet assay. TUNEL assay was also done in the target organ to 
understand the mode of cell death. 
5.2. Materials and methods 
5.2.1. Animals and treatment 
All animal-handling procedures were carried out following the regulations of 
Institutional Animal Ethics Committee and with their prior approval for using 
the animals. Male Swiss albino mice (∼6-week-old, 20 ± 2 g) were obtained 
from the Indian Institute of Toxicology Research (Lucknow, India) animal 
breeding colony and were housed in a 12h day and light cycle environment 
with ad libitum availability of diet and water, at the controlled temperature of 
23 ± oC, humidity of 55 ± 5%. The animals were divided into 3 groups 
containing 25 mice each: Group 1- vehicle control (water); Group 2- ZnO 
nanoparticles (300mg/Kg body weight); Group 3- ZnO nanoparticles 
(50mg/Kg body weight). The animals were treated daily through gavage for  
14 consecutive days according to the fixed dose procedure (OECD-420 
2001).  
All animals were weighed at the beginning and end of each treatment. After 
the treatments, the animals were sacrificed by cervical dislocation. Organs 
were taken out immediately for isolation of single cells. 
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5.2.2. Zn content analysis in tissues 
This has been described in Chapter 2 (2.11.2). 
5.2.3. Biochemical assay of serum 
This has been described in Chapter 2 (2.11.3). 
5.2.4. Lipid peroxidation (LPO) assay 
A 10% homogenate of tissues (liver, kidney and brain) was made in ice cold 
buffer comprising 0.1 M Na2HPO4, 0.1M NaH2PO4 and 0.1M KCl, using a 
Polytron PT 1600 E (KINEMATICA, Switzerland). The homogenate was then 
centrifuged at 9000 x g for 10min and the supernatant was used for the 
enzymatic assay. LPO was measured using the method of Utley et al (1976) 
as described in Chapter 2 (2.11.4.). 
5.2.5. Histopathology 
The mouse organs were fixed in 10% formalin for 24-48h at room 
temperature and the tissues were processed for histopathology as described 
in Chapter 2 (2.11.5.). 
5.2.6. Single cell gel electrophoresis/ Comet assay 
The tissues from mouse organ (liver and kidney) was minced and 
suspended in chilled Hank’s balanced salt solution with 20mM EDTA. The 
cell suspension was then mixed with equal amount of 1% LMPA and the 
slides were prepared and the comet assay performed as previously 
described in Chapter 2 (2.7). 
5.2.7. TUNEL assay 
The method of the TUNEL assay has been described before in Chapter 2 
(2.11.6). 
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5.3. Results 
5.3.1. Body and organ weights of mice 
The three groups of mice did not show any significant difference in the body 
weights. Similarly, no obvious difference was observed in the organ weights 
(liver, kidney and brain) of control mice and ZnO nanoparticles treated mice 
(Table 5.1).  
5.3.2. Zn content analysis 
A significant (p<0.05) increase in the Zn content was found in the liver of 
mice treated with 300mg/Kg ZnO NPs for 14 days compared to the control 
mice. In contrast, there was no difference in Zn content in the brain of 
treated and control mice. The kidney showed a slight increase in the Zn 
content but it was not statistically significant (Figure 5.1). 
5.3.3. Biochemical assays in serum 
The mice orally exposed to ZnO nanoparticles at a dose of 300mg/Kg 
showed a significantly (p < 0.05) higher levels of alanine aminotransferase 
(ALT) and alkaline phosphatase (ALP) compared to control mice (Table 5.2). 
The levels of bilirubin, blood urea nitrogen (BUN) and creatinine were found 
to be similar in both the groups.  
5.3.4. Lipid peroxidation assay 
A significant (p<0.05) induction in the lipid peroxidation was observed at the 
higher dose (300mg/Kg) in the liver and kidney of ZnO nanoparticles 
exposed mice compared to the control group (Table 5.3). The brain showed 
no increase in lipid peroxidation on nanoparticle exposure. 
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5.3.5. Histopathological changes 
The liver and kidney of mice exposed orally to ZnO nanoparticles 
(300mg/Kg) for 14 consecutive days showed pathological alterations. The 
liver revealed hepatocellular necrosis and accumulation of inflammatory cells 
around necrotic area (Figure 5.2A-B). Kidney depicted cystic dilation of 
tubules along with hypertrophied tubules (Figure 5.2C-D).  
5.3.6. Oxidative DNA damage 
The oxidative DNA damage in the liver and kidney cells of mice was 
evaluated by the Fpg- modified Comet assay after an acute oral exposure to 
ZnO nanoparticles. 
Cell viability for all the samples was found to be more than 90% in every 
experiment (data not shown).  
A statistically significant (p<0.05) increase in the oxidative DNA damage was 
observed in the liver of mouse exposed to ZnO NPs at the higher dose (300 
mg/Kg) as was evident by an increase in the Olive tail moment (arbitrary 
units) and Tail DNA (%) (Table 5.4). However, no significant DNA damage 
was observed in the mice administered with the lower dose of ZnO NPs (50 
mg/kg). 
There was no significant difference in the Comet parameters in the kidney 
cells of control and ZnO NPs exposed mice. 
5.3.7. TUNEL assay 
TUNEL assay was done to detect the apoptotic cells in the liver of control 
mice and ZnO NPs exposed mice. An increase in the TUNEL positive (green 
fluorescence) cells scattered throughout the liver section was observed in 
the liver of mice treated with higher dose of ZnO NPs (300 mg/Kg) compared 
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to control mice (Figure 5.3). However, only few TUNEL positive cells were 
visible in the liver section of lower dose group (50 mg/Kg) and control group.  
5.4. Discussion 
In the present study, the acute oral toxicity and genotoxicity of ZnO 
nanoparticles (300 and 50mg/Kg) in mice was investigated after an exposure 
of 14 consecutive days. The oral route was selected as the route of 
exposure for mice. This is because the ZnO nanoparticles are being used in 
food packaging and may gain entry into the body directly. Even when used 
in other consumer products like coating and dermatological applications, 
there is a risk of ingestion during use. Moreover, they may gain entry into the 
gastrointestinal tract after their accidental release into the environment. The 
doses at which humans may be exposed to ZnO nanoparticles in these 
scenarios are yet to be found. We chose to work with the doses that are 
suggested by OECD guidelines for investigating the acute oral toxicity of any 
new substance (OECD-420 2001). These doses do not necessarily reflect 
the actual concentrations of ZnO nanoparticles found in the real 
environments, however, they can be used to assess the health risks from 
prolonged exposure to ZnO nanoparticles. The mice were chosen as the in 
vivo model of exposure because of their similarity with human metabolic, 
biochemical and physiological pathways (Argmann et al. 2005).   
The nanoparticles when ingested into the body can be distributed to different 
regions because of their small size. They can cross small intestine and 
further distribute into the blood, brain, lung, heart, kidney, spleen, liver, 
intestine and stomach (Hillyer and Albrecht 2001). Jani et al. (1990) have 
shown that polystyrene latex nanoparticles when administerated orally can 
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be absorbed across the gastrointestinal tract, and pass through the 
mesentery lymph supply and lymph node to liver and spleen. So it is 
important to find out the information about their bio-distribution. The ZnO 
nanoparticles were mainly found to be retained in the liver after 14 day acute 
exposure in our studies. This was not surprising as the liver is the primary 
organ of metabolism for xenobiotics and the nanoparticles have been 
reported to reach the liver when administrated through the gastro-intestinal 
route (Chen et al. 2006; Cui et al. 2011). 
The targeting of liver by orally administrated ZnO nanoparticles led to the 
liver damage as revealed by the histopathological examination which 
showed hepatocellular necrosis. This was also supported by the ALT and 
ALP levels in the serum.  The levels of these enzymes rise in serum when 
the liver is damaged. The unaltered levels of creatinine, blood urea nitrogen 
and bilirubin in the present study indicated normal renal functions in the ZnO 
nanoparticle exposed group. These results support the findings of Wang et 
al. (2008a) who demonstrated liver damage by the acute oral exposure of 
ZnO nanoparticles for 14 consecutive days although at a higher dose of 
5000mg/Kg. However, the genotoxic and oxidative stress potential of the 
nanoparticles was not examined. Moreover, an increased agglomeration at 
these doses is a problem so the study of toxic responses at lower doses was 
suggested by the authors (Wang et al. 2008a). 
There was absence of mortality in the ZnO nanoparticle exposed groups and 
no difference in the body/organ weights was observed compared to control 
group. This suggests that the exposure did not exert any major visible 
impairment in the health status of animals.  
162 
 
In our in vitro toxicity studies, we observed oxidative stress and subsequent 
oxidative DNA damage in HepG2 cells on exposure to ZnO nanoparticles. 
Therefore, the condition of oxidative stress was also investigated in our in 
vivo experiments by measuring lipid peroxidation in the liver, kidney and 
brain of mice. An increased lipid peroxidation levels were observed in the 
liver of higher dose exposed group compared to the control group indicating 
ZnO nanoparticle induced oxidative stress in the liver. This oxidative stress 
also led to the DNA damage in liver as indicated by a significant increase in 
the Fpg sites in the ZnO nanoparticle exposed group.  
The mechanism of cell death suggested by the in vitro studies was found to 
be oxidative stress induced mitochondria mediated apoptosis. Therefore, the 
phenomenon of apoptosis was also explored in the liver of higher dose (300 
mg/Kg) group by employing TUNEL assay. A significant number of cells 
undergoing apoptosis were found in the mice liver of treated mice compared 
to the control group suggesting that the oxidative stress might also lead to 
apoptosis during the in vivo exposure. 
Although, liver was found to be the target organ of ZnO nanoparticles, the 
kidney also depicted cystic dilation of tubules along with hypertrophied 
tubules. An increased lipid peroxidation in the kidney also demonstrated that 
the ZnO nanoparticle intake also adversely affects the kidney. This suggests 
that nanoparticle may be transported from blood to kidney and a more 
obvious and severe damage in kidney may be expected from a longer 
duration of exposure. Burns et al. (2009) have reported that smaller sized 
nanoparticles (3-6nm) can be effectively cleared out of the animal by renal 
excretion while the bigger sized (approximately 30nm) may be retained in 
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the liver. The glomerular filtration in kidney, which is primarily dependent on 
the size of metabolites, is ineffective in their clearance. For larger 
metabolites, the preferred route of excretion is via hepatobilliary mechanism 
which is a slower mechanism and subsequent long term retention in the 
organ can lead to organ toxicity (Kumar et al. 2010). 
In conclusion, the acute oral exposure of ZnO nanoparticles at 300 mg/Kg 
for 14 consecutive days leads to accumulation of nanoparticles in liver and 
significant liver damage. This was evident by the elevated ALT and ALP 
serum levels and pathological alterations in the liver. The ZnO nanoparticles 
were also found to induce oxidative stress and oxidative DNA damage in the 
liver cells. The hepatocyte apoptosis was also observed which might be 
mediated by the oxidative stress induced mitochondrial pathway as 
demonstrated in our in vitro studies earlier. No damage to the brain of ZnO 
nanoparticle exposed mice was observed.  
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Table 5.1. Body weights and organ weights of mice after oral exposure to 
ZnO nanoparticles. 
 
Values represent mean± SEM of ten animals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Zinc content in selected tissue of the mice (n=5) after oral 
administration of ZnO NPs (300mg/Kg) for 14 consecutive days. Data 
represent mean ± S.E.M. of five animals.*p < 0.05, compared to control. 
 
 
Groups  
Body weight (g) 
Before          After 
Liver 
(mg/g) 
Kidney 
(mg/g) 
Brain 
(mg/g) 
Control 20.5± 0.57 23.9± 0.93 48.2± 0.05 13.1± 0.02 16.23± 0.01
ZnO NPs 
(50mg/Kg) 
20.3± 0.67 23.3± 0.88 51.63± 0.05 13± 0.04 16.86± 0.01
ZnO NPs 
(300mg/Kg) 
20± 0.48 23± 0.92 51.3± 0.03 13.91± 0.01 17.39± 0.02
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Table 5.2. Serum biochemistry parameters in mice after oral exposure to 
ZnO nanoparticles (300mg/kg) for 14 consecutive days. 
 
 
 
 
 
 
 
 
 
 
 
                 Values represent mean ± S.E of five animals. 
      * p < 0.05; ** p < 0.01 when compared to control. 
 
 
 
 
 
 
 
 
Table 5.3. Effect of ZnO NPs on lipid peroxidation (LPO)a in different organs 
of mouse.  
  Values represent mean ± S.E of five animals. 
  a LPO expressed as nmol MDA formed/h/g tissue. 
 *p<0.05, significant when compared to the control group. 
 
 
 
Parameters 
Groups  
Control         Treated 
ALT (U/L) 55± 5 98± 8.2* 
ALP (U/L) 103± 7.3 624± 14.6** 
Bilirubin (mg/dl) 0.24± 0.01 0.26± 0.03 
BUN (mg/dl) 31± 0.76 26± 3.4 
Creatinine (mg/dl) 0.43± 0.03 0.42± 0.04 
Organs Control  
ZnO NPs 
(50mg/Kg.b.wt.) 
 
ZnO NPs 
(300mg/Kg.b.wt.) 
 
Liver 0.42± 0.01 0.43± 0.02 0.62± 0.01* 
Kidney 0.27± 0.02 0.29± 0.01 
 
0.90± 0.01* 
 
Brain 
 
1.19± 0.03 1.09± 0.02 1.25± 0.01 
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Figure 5.2.Histopathology of liver and kidney tissues in mice treated with 
ZnO NPs for 14 consecutive days (A-B) Control group showing normal liver 
and kidney (B-C) Pathological alterations in the liver (hepatocellular 
necrosis) and kidney (hypertrophied tubules) of ZnO NPs (300mg/Kg) 
treated group (indicated by arrow); Magnification (X200). 
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Table 5.4. Effect of ZnO NPs on Comet parameters in liver and kidney cells 
of mice after oral exposure to ZnO nanoparticles for 14 consecutive days. 
 
Liver 
 
OTM (arbitrary unit) Tail DNA (%) 
Fpg (-) Fpg (+) Fpg (-) Fpg (+) 
Control 1.2± 0.1 1.38± 0.12 11.43± 0.92 13.12± 0.31 
ZnO NPs 
 (50 mg/Kg) 
1.38± 0.08 1.19± 0.06 12.6± 1.02 11.88± 0.66 
ZnO NPs  
(300 mg/Kg) 
1.15± 0.04 2.13± 0.13*α 11.02± 0.77 16.15± 1.56α 
Kidney 
 
OTM (arbitrary unit) Tail DNA (%) 
Fpg (-) Fpg (+) Fpg (-) Fpg (+) 
Control 0.97± 0.13 1.33± 0.09 9.91± 1.28  11.91± 1.54 
ZnO NPs 
 (50 mg/Kg) 
1.25± 0.11 1.37± 0.23 12.56± 1.51 11.76± 1.54 
ZnO NPs  
(300 mg/Kg) 
1.17± 0.03 1.27± 0.18 11.04± 0.93 10.89± 0.54 
Values represent mean ± S.E.M of five animals. 
* p < 0.05 when compared to control using one way ANOVA 
α p < 0.05 when compared to Fpg (-) at the same dose using Student ‘t’ test. 
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Figure 5.3. ZnO NPs induced apoptosis in the liver cells of mice as detected 
by the TUNEL assay. Representative images (X400) of TUNEL positive cells 
(green fluorescence) in the liver sections of (A) Control mice (B-C) Mice 
exposed to ZnO NPs (300 and 50 mg/Kg) through oral route for 14 
consecutive days.  
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GENERAL DISCUSSION 
6.1. General discussion 
The lack of information regarding the safety/ toxicity of nanomaterials poses 
environmental health and safety (EHS) issues. Therefore it is necessary that 
researchers in toxicology and chemistry as well as other related scientific 
fields analyze the potential toxic effects of engineered nanoparticles along 
with their positive aspects.  
ZnO nanoparticle is one such widely used enginered nanoparticle in the 
world consumer market. This makes human beings more prone to ZnO 
nanoparticle exposure and its adverse effects. In the present study, an 
attempt was made to evaluate the in vitro and in vivo toxicity of ZnO 
nanoparticles in the mammalian system and to elucidate the possible 
mechanism of its toxicity. The human epidermal cells (A431 cells and 
primary human epidermal keratinocytes) and human liver cells (HepG2) 
were selected for assessing ZnO nanoparticle toxicity keeping in view the 
fact that ZnO nanoparticle are used in cosmetics and food packaging. The 
results demonstrate that ZnO nanoparticles have cytotoxic and genotoxic 
potential in both in vitro and in vivo mammalian systems. The concentrations 
of ZnO nanaoparticles inducing cytotoxicity were found to be different in 
different cell types (A431 cells, primary human epidermal keratinocytes and 
HepG2 cells). This difference can be attributed to the dissimilarties between 
the growth properties and the biochemical characteristics of these cells. For 
instance, the concentrations of ZnO nanoparticles that lead to cytotoxicity in 
HepG2 cells were found to be higher compared to the cytotoxic 
concentations in A431 cells. This is due to the fact that the liver cells 
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(HepG2) are metabolically more active and resistant than the skin cells 
(A431).  
ZnO nanoparticle exposure leads to reactive oxygen species (ROS) 
generation and lipid peroxidation (LPO). The ROS triggered decrease in 
mitochondrial membrane potential and increase in ratio of Bax/Bcl2 leading 
to mitochondria mediated pathway involved in apoptosis. In addition, ZnO 
nanoparticles activated JNK, P38 and induced P53ser15 phosphorylation, 
however, the apoptosis was found to be independent of JNK and P38 
pathways. The data also suggests that the nanoparticle dissolution does not 
play a significant role in ZnO nanoparticle induced toxicity. DNA damage 
was also found to be mediated by the oxidative stress as evidenced by 
increase in Fpg sensitive sites in the DNA. 
The in vitro findings were further extrapolated to the in vivo experiments in 
mice. The mice were exposed to ZnO nanoparticles (300mg/Kg and 
50mg/Kg) via the oral route for 14 consecutive days according to the OECD 
guidelines. The ZnO nanoparticles were mainly retained in the liver and 
caused lipid peroxidation and oxidative DNA damage. The hepatic cells of 
mice exposed to higher dose showed apoptosis compared to the control 
mice. 
The results from the present study provide significant data regarding the 
toxicity of ZnO nanoparticles as well as the underlying molecular mechanism 
involved. The results also stress upon the need of a thorough toxicity 
assessment of any novel engineered nanomaterial before their arrival into 
the world consumer market. This will ensure that the society fully benefits 
from the nanotechnology while avoiding its potential adverse effects. 
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6.2. Future work 
The study could be further improved by the following: 
1. Determining the role of TNF alpha and extrinsic apoptotic pathway in 
ZnO nanoparticle induced apoptosis.  
2. Investigating the effect of different sizes of ZnO nanoparticles on 
cellular responses. 
3.  Elucidating the changes in gene expression and metabolic profile of 
ZnO nanoparticles exposed cells. 
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